<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicina (Kaunas)</journal-id><journal-id journal-id-type="iso-abbrev">Medicina (Kaunas)</journal-id><journal-id journal-id-type="publisher-id">medicina</journal-id><journal-title-group><journal-title>Medicina</journal-title></journal-title-group><issn pub-type="ppub">1010-660X</issn><issn pub-type="epub">1648-9144</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7997252</article-id><article-id pub-id-type="pmid">33673527</article-id><article-id pub-id-type="doi">10.3390/medicina57030217</article-id><article-id pub-id-type="publisher-id">medicina-57-00217</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Antiviral and Immunomodulation Effects of Artemisia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kshirsagar</surname><given-names>Suhas G.</given-names></name><xref ref-type="aff" rid="af1-medicina-57-00217">1</xref><xref rid="c1-medicina-57-00217" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Rammohan V.</given-names></name><xref ref-type="aff" rid="af2-medicina-57-00217">2</xref><xref rid="c1-medicina-57-00217" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Schneider</surname><given-names>Robert H.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-medicina-57-00217"><label>1</label>College of Ayurveda, Mount Madonna Institute, 445 Summit Road, Watsonville, CA 95076, USA</aff><aff id="af2-medicina-57-00217"><label>2</label>California College of Ayurveda, 700 Zion Street, Nevada City, CA 95959, USA</aff><author-notes><corresp id="c1-medicina-57-00217"><label>*</label>Correspondence: <email>drsuhashi@yahoo.com</email> (S.G.K.); <email>rrao2006@gmail.com</email> (R.V.R.)</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2021</year></pub-date><volume>57</volume><issue>3</issue><elocation-id>217</elocation-id><history><date date-type="received"><day>23</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>25</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Background and Objectives:</italic> Artemisia is one of the most widely distributed genera of the family Astraceae with more than 500 diverse species growing mainly in the temperate zones of Europe, Asia and North America. The plant is used in Chinese and Ayurvedic systems of medicine for its antiviral, antifungal, antimicrobial, insecticidal, hepatoprotective and neuroprotective properties. Research based studies point to Artemisia&#x02019;s role in addressing an entire gamut of physiological imbalances through a unique combination of pharmacological actions. Terpenoids, flavonoids, coumarins, caffeoylquinic acids, sterols and acetylenes are some of the major phytochemicals of the genus. Notable among the phytochemicals is artemisinin and its derivatives (ARTs) that represent a new class of recommended drugs due to the emergence of bacteria and parasites that are resistant to quinoline drugs. This manuscript aims to systematically review recent studies that have investigated artemisinin and its derivatives not only for their potent antiviral actions but also their utility against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). <italic>Materials and Methods</italic>: PubMed Central, Scopus and Google scholar databases of published articles were collected and abstracts were reviewed for relevance to the subject matter. <italic>Conclusions</italic>: The unprecedented impact that artemisinin had on public health and drug discovery research led the Nobel Committee to award the Nobel Prize in Physiology or Medicine in 2015 to the discoverers of artemisinin. Thus, it is clear that Artemisia&#x02019;s importance in indigenous medicinal systems and drug discovery systems holds great potential for further investigation into its biological activities, especially its role in viral infection and inflammation.</p></abstract><kwd-group><kwd>Artemisia</kwd><kwd>Artemisinin</kwd><kwd>ARTs</kwd><kwd>phytochemicals</kwd><kwd>SARS-CoV-2</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-medicina-57-00217"><title>1. Introduction</title><p>Medicinal plants, which are undervalued, have an important place in modern medicine owing to the multitude of active principles that nature provided through millions of years of evolution. These numerous plant chemicals or phytochemicals possess far reaching, biologically active, beneficial effects and provide protection to the plants from insects, bacteria, virus and other predators. These phytochemicals either alone or in combination affect multiple pathways simultaneously to produce the desired pharmacological effect. Many medicinal plants or herbs are revered by the ancient medical traditions (Chinese medicine, Ayurveda, Native Americans, etc.) due to their healing benefits and about 40% of modern medicines are derived from plants [<xref rid="B1-medicina-57-00217" ref-type="bibr">1</xref>,<xref rid="B2-medicina-57-00217" ref-type="bibr">2</xref>,<xref rid="B3-medicina-57-00217" ref-type="bibr">3</xref>]. The development of antibacterial and anti-infectious agents is a major focus in modern medical research. Plant-based antiviral formulations have been studied for their therapeutic potential in the management of various viral diseases including influenza, human immunodeficiency virus (HIV), herpes simplex virus (HSV), hepatitis, and coxsackievirus infections [<xref rid="B4-medicina-57-00217" ref-type="bibr">4</xref>,<xref rid="B5-medicina-57-00217" ref-type="bibr">5</xref>,<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B7-medicina-57-00217" ref-type="bibr">7</xref>]. </p><p>One particular plant that has garnered a lot of attention in lieu of the COVID-19 epidemic is Artemisia which is one of the largest and most widely distributed genera of the family Astraceae (Compositae) [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B8-medicina-57-00217" ref-type="bibr">8</xref>]. Artemisia is a varied genus consisting of more than 500 diverse species and is found in the temperate zones of Europe, Asia and North America [<xref rid="B9-medicina-57-00217" ref-type="bibr">9</xref>,<xref rid="B10-medicina-57-00217" ref-type="bibr">10</xref>,<xref rid="B11-medicina-57-00217" ref-type="bibr">11</xref>]. Evidence-based in vitro and in vivo studies on several species of Artemisia resulted in the identification of numerous phytochemicals with varied pharmacological activities, including terpenoids, flavonoids, coumarins, caffeoylquinic acids and sterols [<xref rid="B12-medicina-57-00217" ref-type="bibr">12</xref>,<xref rid="B13-medicina-57-00217" ref-type="bibr">13</xref>]. The first clinical trial of Artemisia extract in human patients with malaria was conducted in August 1972. Following that trial, the active compound in the Artemisia extract was isolated and identified as artemisinin. Several derivatives or synthetic compounds with key structures similar to artemisinin have now been developed including artesunate and piperaquine from <italic>A. annua</italic> and piperitone and trans-ethyl cinnamate from <italic>A. judaica</italic> that have potent antiviral and anti-inflammatory activities [<xref rid="B9-medicina-57-00217" ref-type="bibr">9</xref>,<xref rid="B14-medicina-57-00217" ref-type="bibr">14</xref>,<xref rid="B15-medicina-57-00217" ref-type="bibr">15</xref>,<xref rid="B16-medicina-57-00217" ref-type="bibr">16</xref>]. A combination of artemisinin and its derivatives (ARTs) is now recommended by the World Health Organization (WHO) for the treatment of malaria. </p></sec><sec sec-type="methods" id="sec2-medicina-57-00217"><title>2. Methods</title><p>For the review, we conducted a search of PubMed Central, Scopus and Google scholar databases of articles published from 2000 to 2020 to include the most recent literature. The search was limited to articles in English and abstracts were reviewed for relevance to the subject matter of pharmacological perspective on Artemisia. Articles containing combinations of MeSH terms &#x02018;Artemisia&#x02019; &#x02018;artemisinin&#x02019;, &#x02018;artesunate&#x02019;, &#x02018;phytochemistry&#x02019;, &#x02018;diseases or conditions&#x02019;, &#x02018;in vitro or in vivo experiments&#x02019;, &#x02018;COVID-19&#x02032;, &#x02018;SARS-CoV-2&#x02032; and &#x02018;mechanistic actions&#x02019; were collected. Boolean terms (AND/OR/NOT) were added to combine or exclude keywords in the search resulting in more focused literature. </p></sec><sec id="sec3-medicina-57-00217"><title>3. Ethnopharmacology</title><p>The isolation and identification of potent compounds from the genus Artemisia, particularly artemisinin and its derivatives using novel drug discovery methods, prompted the Nobel Committee to award the Nobel Prize in Physiology or Medicine in 2015 for its impact on public health [<xref rid="B17-medicina-57-00217" ref-type="bibr">17</xref>,<xref rid="B18-medicina-57-00217" ref-type="bibr">18</xref>]. This spurred the interest of several researchers to study the phytochemical and pharmacological properties of other species of the genus Artemisia. </p><p>Nearly 45 different species of Artemisia grow in India and in the Indian subcontinent and is mainly used as a medicinal plant [<xref rid="B8-medicina-57-00217" ref-type="bibr">8</xref>,<xref rid="B19-medicina-57-00217" ref-type="bibr">19</xref>]. Ayurveda describes two species <italic>A</italic>. <italic>absinthium</italic> and <italic>A. maritima,</italic> popularly known as Mugwort that vary slightly in their qualities and actions as shown in <xref rid="medicina-57-00217-t001" ref-type="table">Table 1</xref>. </p><p>In the Ayurvedic system of medicine, the term &#x02018;<italic>prabhava</italic>&#x02019; refers to the &#x02018;instinct intelligence&#x02019; of a plant in eliciting a wide range of medicinal effects [<xref rid="B21-medicina-57-00217" ref-type="bibr">21</xref>,<xref rid="B22-medicina-57-00217" ref-type="bibr">22</xref>]. <italic>A</italic>. <italic>absinthium</italic> and <italic>A. maritima</italic> are revered, owing to their <italic>prabhava</italic> and are recommended in Ayurveda for infections, inflammation, skin and liver diseases, respiratory conditions, neurological conditions and as an insecticidal (<italic>krimighna</italic>) [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B8-medicina-57-00217" ref-type="bibr">8</xref>]. </p><p>The pharmacological actions and properties of the various Artemisia species from several geographic locations are listed in <xref rid="medicina-57-00217-t002" ref-type="table">Table 2</xref>. Basically, the plant has been used as an anti-malarial, anti-spasmodic, anti-inflammatory, febrifuge, cardiac stimulant, anthelmintic, headaches, dyspepsia, liver and kidney tonic, to improve memory, for digestive and respiratory issues and as a hypertensive and anticoagulant.</p><p>The wide variety of actions stems from the fact that these various species of Artemisia possess high content of alkaloids, lactones, flavonoids, phenols, quinines, tannins and terpenoids all of which play a role in the growth of the plant or provide protection from pathogens or predators [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B9-medicina-57-00217" ref-type="bibr">9</xref>,<xref rid="B44-medicina-57-00217" ref-type="bibr">44</xref>,<xref rid="B45-medicina-57-00217" ref-type="bibr">45</xref>]. </p></sec><sec id="sec4-medicina-57-00217"><title>4. In Vitro and In Vivo Studies</title><p>We review some of the recent in vivo and in vitro studies of various extracts and formulations of Artemisia. The research studies utilized aqueous, methanol, chloroform or acetone extracts, essential oils or oil based extracts or dried powders of various species of Artemisia. The studies were performed on bacterial, viral or fungal cultures, cultured cells or animal models with limited studies on humans. </p><p>In the light of the COVID-19 pandemic, some species of Artemisia including but not limited to <italic>A. annua</italic>, <italic>A. absinthium</italic>, <italic>A. vulgaris</italic>, <italic>A. maritima</italic> and <italic>A. indhana</italic> are receiving greater attention from researchers as they hold great potential for their powerful anti-infectious, antiviral and anti-inflammatory activities [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B12-medicina-57-00217" ref-type="bibr">12</xref>,<xref rid="B46-medicina-57-00217" ref-type="bibr">46</xref>,<xref rid="B47-medicina-57-00217" ref-type="bibr">47</xref>,<xref rid="B48-medicina-57-00217" ref-type="bibr">48</xref>]. Recent studies are now pointing to the exciting roles of artemisinin and its derivatives (ARTs) as potential drug candidates against SARS-CoV-2 owing to their potent antiviral and anti-inflammatory properties. </p><sec id="sec4dot1-medicina-57-00217"><title>4.1. Anti-Carcinogenic Activity</title><p>Various species of the Artemisia plant have been shown to suppress the growth of numerous cancer cell lines including leukemia, colon cancer, renal cell carcinoma and breast cancer cells [<xref rid="B28-medicina-57-00217" ref-type="bibr">28</xref>,<xref rid="B49-medicina-57-00217" ref-type="bibr">49</xref>,<xref rid="B50-medicina-57-00217" ref-type="bibr">50</xref>]. Phytochemical analysis of the various extracts revealed the presence of coumarins, flavonoids, anthocyanins, cardiac glycosides and tannins. These phytochemicals and their derivatives exhibit growth inhibitory properties through multiple actions including blocking angiogenesis, triggering apoptosis or cell cycle arrest and disrupting cell migration [<xref rid="B51-medicina-57-00217" ref-type="bibr">51</xref>,<xref rid="B52-medicina-57-00217" ref-type="bibr">52</xref>,<xref rid="B53-medicina-57-00217" ref-type="bibr">53</xref>]. Researchers are now focusing their efforts on ARTs that appear to be broad-spectrum antitumor agents based on their efficacy and safety [<xref rid="B54-medicina-57-00217" ref-type="bibr">54</xref>,<xref rid="B55-medicina-57-00217" ref-type="bibr">55</xref>]. </p><p>In a randomized, double-blind, placebo-controlled pilot trial involving 23 subjects, the anticancer effect and tolerability of oral artesunate in colorectal cancer (CRC) was determined. The primary outcome measure was the proportion of tumor cells undergoing apoptosis. Despite the fact that it was a small study size with variability in quantitating immunohistochemical markers, the results clearly indicated selective cytotoxicity of oral artesunate. </p><p>In addition to the above mentioned study, other clinical trials involving patients with solid tumors including colorectal carcinoma, breast cancer, hepatocellular carcinoma and lung cancer have been completed with encouraging results. In all these studies, ARTs inhibited growth of solid tumors with no evident toxicity and with a low incidence of adverse effects thus highlighting their role as promising anti-cancer agents [<xref rid="B54-medicina-57-00217" ref-type="bibr">54</xref>,<xref rid="B56-medicina-57-00217" ref-type="bibr">56</xref>,<xref rid="B57-medicina-57-00217" ref-type="bibr">57</xref>].</p></sec><sec id="sec4dot2-medicina-57-00217"><title>4.2. Anti-Oxidant Activity</title><p>The phytochemicals and their derivatives, extracts and essential oils derived from the Artemisia plant have a unique property of being reactive oxygen species (ROS) modulators. In some cases they exhibit strong antioxidant and radical scavenging activity against hydroxyl ion and hydrogen peroxide and display excellent protective effect by strengthening the antioxidant defense system and lowering the generation of ROS [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B58-medicina-57-00217" ref-type="bibr">58</xref>].</p><p>In other situations, especially involving cancer cells, ARTs triggered ROS production leading to mitochondrial dysfunction and autophagy of leukemia cell lines. ARTs-induced ROS production triggered apoptosis in various tumor cell lines studies, including neuroblastoma, glioblastoma, T-cell lymphoma and breast cancer cells [<xref rid="B54-medicina-57-00217" ref-type="bibr">54</xref>]. In studies using mouse models of cancer, ARTs induced ROS production leading to the inhibition of growth of ovarian cancer [<xref rid="B54-medicina-57-00217" ref-type="bibr">54</xref>]. </p><p>The mechanism of action of ARTs involves binding to ferrous iron (e.g., heme) and triggering the generation of ROS, which results in cytostatic or cytotoxic effects. The production of ROS can also trigger cellular damage through the peroxidation of membrane lipids, activation of pro-apoptotic pathways or creating genomic and mitochondrial DNA instability [<xref rid="B59-medicina-57-00217" ref-type="bibr">59</xref>]. Thus, the ROS modulating properties exhibited by the various phytochemicals isolated from different species of Artemisia highlight the importance of exploring the therapeutic uses of these compounds in pathological conditions that feature oxidative stress. </p></sec><sec id="sec4dot3-medicina-57-00217"><title>4.3. Anti-Bacterial and Anti-Parasitic Activity</title><p>The plant extracts and compounds obtained from Artemisia species have been shown to be powerful inhibitors of bacteria and parasites [<xref rid="B9-medicina-57-00217" ref-type="bibr">9</xref>]. Mechanistic studies demonstrate the bactericidal properties of some of these phytochemicals against Gram-negative or Gram-positive bacteria involving the destruction of the bacterial membrane [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B28-medicina-57-00217" ref-type="bibr">28</xref>,<xref rid="B60-medicina-57-00217" ref-type="bibr">60</xref>,<xref rid="B61-medicina-57-00217" ref-type="bibr">61</xref>]. Notable among the phytochemicals is ARTs that represent a new class of antibacterial drugs [<xref rid="B9-medicina-57-00217" ref-type="bibr">9</xref>,<xref rid="B14-medicina-57-00217" ref-type="bibr">14</xref>,<xref rid="B15-medicina-57-00217" ref-type="bibr">15</xref>].</p><p>ARTs also possess potent antimalarial properties and are effective against both asexual and sexual parasite stages. In several clinical trials involving both ARTs and quinine, ARTs outperformed quinine in terms of mean parasite clearance time, fever clearance time, coma resolution times and incidence of adverse effects [<xref rid="B14-medicina-57-00217" ref-type="bibr">14</xref>,<xref rid="B15-medicina-57-00217" ref-type="bibr">15</xref>,<xref rid="B16-medicina-57-00217" ref-type="bibr">16</xref>,<xref rid="B62-medicina-57-00217" ref-type="bibr">62</xref>]. Artemisinin-based therapies are now recommended due to the resistance displayed by bacteria and parasites to quinoline drugs.</p></sec><sec id="sec4dot4-medicina-57-00217"><title>4.4. Anti-Fibrotic Effects</title><p>In addition to the above mentioned pharmacological properties, ARTs are also known for their anti-fibrotic effects [<xref rid="B29-medicina-57-00217" ref-type="bibr">29</xref>,<xref rid="B63-medicina-57-00217" ref-type="bibr">63</xref>,<xref rid="B64-medicina-57-00217" ref-type="bibr">64</xref>]. The role of ARTs in blocking the development or progression of fibrotic phenotypes has been studied in animal models of pulmonary fibrosis, renal fibrosis, hepatic fibrosis, and other types of tissue fibrosis suggesting the potential utility of these compounds as anti-fibrotic agents. The effects of ARTs against profibrotic processes include induction of apoptosis, inhibition of proliferation, blocking differentiation of tissue-specific myofibroblast precursors or preventing the accumulation of tissue myofibroblasts that provoke tissue fibrosis [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B63-medicina-57-00217" ref-type="bibr">63</xref>]. In addition, ARTs block the expression of extracellular matrix (ECM) genes and pro-fibrotic genes in myofibroblasts thereby antagonizing cellular processes that promote accumulation of fibrotic tissue. ARTs also inhibit angiogenesis either through direct effects on endothelial cells or indirectly by downregulating pro-angiogenic gene expression in angiogenesis-supporting non-endothelial cells. With its anti-fibrotic role in disease models across several species and multiple tissues involving diverse mechanisms, artemisinin-based therapeutics for treatment of fibrotic diseases may prove efficacious in humans [<xref rid="B64-medicina-57-00217" ref-type="bibr">64</xref>].</p></sec><sec id="sec4dot5-medicina-57-00217"><title>4.5. Role in Neurodegeneration</title><p>Extracts of several Artemisia species exhibit neuroprotective effects against focal ischemia-reperfusion-induced cerebral injury, microglial cytotoxicity and glutamate excitotoxicity [<xref rid="B65-medicina-57-00217" ref-type="bibr">65</xref>]. Furthermore, Artemisia protects neurons against mitochondrial potential loss, attenuates reactive oxygen species and protects neurons against H<sub>2</sub>O<sub>2</sub>-induced death by upregulating the Nrf2 pathway [<xref rid="B66-medicina-57-00217" ref-type="bibr">66</xref>]. ARTs improve learning and memory in mouse models of Alzheimer&#x02019;s disease mice by blocking A&#x003b2;25-35-induced increase in the levels of inflammatory cytokines IL-1&#x003b2;, IL-6 and TNF-&#x003b1; and by restoring the autophagic flux and promoting the clearance of A&#x003b2; fibrils [<xref rid="B67-medicina-57-00217" ref-type="bibr">67</xref>,<xref rid="B68-medicina-57-00217" ref-type="bibr">68</xref>]. </p><p>Recently, three different subtypes of Alzheimer&#x02019;s disease (AD) have been described [<xref rid="B69-medicina-57-00217" ref-type="bibr">69</xref>]. The type-3 AD classified as infectious or Krimi (ayurveda classification of AD) is the result of exposure to virus or biotoxins, such as mycotoxins, and features chronic inflammation [<xref rid="B69-medicina-57-00217" ref-type="bibr">69</xref>,<xref rid="B70-medicina-57-00217" ref-type="bibr">70</xref>]. Owing to their powerful antiviral and anti-inflammatory properties, ARTs may serve as excellent drug candidates for type-3 AD. </p></sec><sec id="sec4dot6-medicina-57-00217"><title>4.6. Anti-Inflammatory Activity</title><p>Artemisia species exhibit powerful anti-inflammatory effects. Several sesquiterpenes derived from Artemisia and their derivatives including artemisinin, artesunate, dihydroarteannuin, artemisolide, eupatilin, scoparone, capillarisin and scopoletin have received special attention due to their role in blocking inflammation. Using animal models, ARTs were found to be effective in treating inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and allergic disorders [<xref rid="B71-medicina-57-00217" ref-type="bibr">71</xref>]. </p><p>Some of the anti-inflammatory mechanisms include: (1) inhibition of the iNOS and COX-2 pathways; (2) suppression of ERK and NF-&#x003ba;B signaling; (3) inhibition of pathogenic T cell activation; (4) suppressing B cells activation and antibody production; and (5) inhibition of Akt phosphorylation and I&#x003ba;B degradation through the PI3K/Akt signaling pathway downstream of TNF-&#x003b1; [<xref rid="B72-medicina-57-00217" ref-type="bibr">72</xref>,<xref rid="B73-medicina-57-00217" ref-type="bibr">73</xref>,<xref rid="B74-medicina-57-00217" ref-type="bibr">74</xref>,<xref rid="B75-medicina-57-00217" ref-type="bibr">75</xref>]. Thus, the varied mechanisms through which these phytochemicals derived from Artemisia exhibit their anti-inflammatory effects warrant investigation into their role as therapeutic candidates for inflammatory conditions and autoimmune disorders.</p></sec><sec id="sec4dot7-medicina-57-00217"><title>4.7. Anti-Viral</title><p>Several phytochemicals isolated from various Artemisia species exhibit significant antiviral activity [<xref rid="B76-medicina-57-00217" ref-type="bibr">76</xref>]. ARTs have turned out to be the most promising antiviral drug candidates with activities against hepatitis B and C viruses, human herpes viruses HSV-1 and HSV-2, HIV-1 and influenza virus A in the low micromolar range [<xref rid="B77-medicina-57-00217" ref-type="bibr">77</xref>,<xref rid="B78-medicina-57-00217" ref-type="bibr">78</xref>,<xref rid="B79-medicina-57-00217" ref-type="bibr">79</xref>,<xref rid="B80-medicina-57-00217" ref-type="bibr">80</xref>,<xref rid="B81-medicina-57-00217" ref-type="bibr">81</xref>,<xref rid="B82-medicina-57-00217" ref-type="bibr">82</xref>]. In most cases, ARTs inhibited the central regulatory processes of viral-infected cells (NF-&#x003ba;B or Sp1-dependent pathways), thus blocking the host-cell&#x02013;type and metabolic requirements for viral replication [<xref rid="B80-medicina-57-00217" ref-type="bibr">80</xref>]. </p><p>Owing to their potent anti-inflammatory, immunoregulatory and antiviral properties, ARTs are being pursued for their activity against SARS-CoV-2 infection. Researchers used in silico approaches to investigate if artemisinin or its derivatives could physically bind any of the COVID-19 target proteins including SARS-CoV-2 spike glycoprotein, spike ectodomain structural protein, the main protease of the virus (M<sup>Pro</sup>) or spike receptor-binding domain, thereby preventing SARS-CoV-2 from binding to the host receptor ACE2 [<xref rid="B83-medicina-57-00217" ref-type="bibr">83</xref>,<xref rid="B84-medicina-57-00217" ref-type="bibr">84</xref>,<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B86-medicina-57-00217" ref-type="bibr">86</xref>,<xref rid="B87-medicina-57-00217" ref-type="bibr">87</xref>,<xref rid="B88-medicina-57-00217" ref-type="bibr">88</xref>,<xref rid="B89-medicina-57-00217" ref-type="bibr">89</xref>]. ADMET (absorption, distribution, metabolism, excretion and toxicity) analysis of artemisinin showed that it was non-cytotoxic, had good aqueous solubility and a good permeability through the blood&#x02013;brain barrier with a promising therapeutic potential. Furthermore, molecular docking studies revealed that artemisinin bound to all four proteins and in some cases displayed better binding modes than hydroxychloroquine [<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B86-medicina-57-00217" ref-type="bibr">86</xref>,<xref rid="B87-medicina-57-00217" ref-type="bibr">87</xref>,<xref rid="B88-medicina-57-00217" ref-type="bibr">88</xref>,<xref rid="B89-medicina-57-00217" ref-type="bibr">89</xref>]. Thus, ARTs could serve as best leads for further drug development process for SARS-CoV-2 infection.</p><p>Several investigators have now shown that extracts from different species of Artemisia are active against SARS-CoV-2 [<xref rid="B79-medicina-57-00217" ref-type="bibr">79</xref>,<xref rid="B86-medicina-57-00217" ref-type="bibr">86</xref>,<xref rid="B90-medicina-57-00217" ref-type="bibr">90</xref>,<xref rid="B91-medicina-57-00217" ref-type="bibr">91</xref>]. Results from recent studies indicate that ARTs impair SARS-CoV-2 viral infection by modulating several host cell metabolic pathways thus making them attractive candidates for COVID-19 [<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B86-medicina-57-00217" ref-type="bibr">86</xref>,<xref rid="B92-medicina-57-00217" ref-type="bibr">92</xref>]. The mechanism of antiviral activity may be through the induction of cellular ROS, blunting the PI3K/Akt/p70S6K signaling pathway, binding to NF-&#x003ba;B/Sp1 or inducing a endocytosis inhibition mechanism, all of which lead to inhibition of viral replication and growth [<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B93-medicina-57-00217" ref-type="bibr">93</xref>,<xref rid="B94-medicina-57-00217" ref-type="bibr">94</xref>]. The above mentioned results have spurred the interest of few groups to embark on clinical trials to evaluate the safety and efficacy of ARTs in the treatment of subjects with SARS-CoV-2 viral infection.</p><p>In a recently published controlled clinical trial, 41 patients with confirmed COVID-19 were divided into two groups. While 18 subjects served as the control group, the experimental group (<italic>n</italic> = 23) received a combination of artemisinin-piperaquine (AP). AP was orally administrated with a loading dose of two tablets (artemisinin 125 mg and piperaquine 750 mg) on the first day, followed by a low dose of one tablet/day (artemisinin 62.5 mg and piperaquine 375 mg) for six days [<xref rid="B95-medicina-57-00217" ref-type="bibr">95</xref>]. The primary outcome was the percentage of participants with undetectable SARS-CoV-2 on days 7, 10, 14, and 28 following the treatment. The results indicated that: (1) the average time to achieve undetectable SARS-CoV-2 RNA in the AP group was significantly less than that in the control group; (2) the elimination rate of SARS-CoV-2 RNA in the AP group was significantly higher than that in the control group; and (3) the length of hospital stay for the AP group was significantly lower than that in the control group. Although the study had insufficient sample size and trial design, nevertheless, the safe toxicity profile and immunoregulatory activities makes AP an excellent drug candidate against SARS-CoV-2 infection [<xref rid="B95-medicina-57-00217" ref-type="bibr">95</xref>].</p><p>Transforming Growth Factor-beta (TGF-&#x003b2;) plays an important role in modulating the immune system and displays different activities on different types of immune cells. SARS-CoV-2 infection is accompanied by a cytokine storm together with edema and pulmonary fibrosis at the end stage of the infection. SARS-CoV-2 also up-regulates TGF-&#x003b2; expression which may partly explain the cytokine storm and fibrosis in the lung [<xref rid="B94-medicina-57-00217" ref-type="bibr">94</xref>,<xref rid="B96-medicina-57-00217" ref-type="bibr">96</xref>,<xref rid="B97-medicina-57-00217" ref-type="bibr">97</xref>]. Efforts are underway to discover novel and specific small molecules that can potently block TGF-&#x003b2; expression with negligible side-effects. Artemisinin and its derivatives have been shown to be suppressors of TGF-&#x003b2; in several models of inflammatory diseases [<xref rid="B64-medicina-57-00217" ref-type="bibr">64</xref>,<xref rid="B98-medicina-57-00217" ref-type="bibr">98</xref>,<xref rid="B99-medicina-57-00217" ref-type="bibr">99</xref>,<xref rid="B100-medicina-57-00217" ref-type="bibr">100</xref>]. A randomized, open-label Phase IV study is underway to evaluate the safety and efficacy of a proprietary formulation of ARTs in adult COVID-19 patients with symptomatic mild-moderate COVID-19 [<xref rid="B101-medicina-57-00217" ref-type="bibr">101</xref>]. In addition to its potent antiviral activity, the drug is expected to mitigate the TGF-&#x003b2; mediated inflammatory injury associated with the cytokine storm and viral sepsis in these patients. Initial results show that the ARTs-based drug has a very favorable safety profile and significantly accelerated the recovery of patients with mild-moderate COVID-19 infection [<xref rid="B101-medicina-57-00217" ref-type="bibr">101</xref>]. Thus inhibition of TGF-&#x003b2; signaling by ARTs may be an attractive therapeutic strategy making them excellent drug candidates against SARS-CoV-2 infection.</p></sec></sec><sec sec-type="conclusions" id="sec5-medicina-57-00217"><title>5. Conclusions and Future Direction</title><p>Several phytochemical derivatives and lead molecules have been developed from medicinal plants for various significant therapeutic activities [<xref rid="B4-medicina-57-00217" ref-type="bibr">4</xref>,<xref rid="B5-medicina-57-00217" ref-type="bibr">5</xref>,<xref rid="B94-medicina-57-00217" ref-type="bibr">94</xref>,<xref rid="B102-medicina-57-00217" ref-type="bibr">102</xref>,<xref rid="B103-medicina-57-00217" ref-type="bibr">103</xref>]. Scientists routinely investigate medicinal plants just for that one single and potent compound responsible for the therapeutic effect [<xref rid="B104-medicina-57-00217" ref-type="bibr">104</xref>]. Studies comparing the action of whole plant extracts to the action of purified preparation show that, in many cases, the potency of the purified preparation declines at each step of fractionation [<xref rid="B105-medicina-57-00217" ref-type="bibr">105</xref>]. Since the therapeutic effect may be the result of the combination of several compounds present in the medicinal plant, a complex mixture of compounds has a greater effect than isolated compounds [<xref rid="B106-medicina-57-00217" ref-type="bibr">106</xref>]. The advantages of a combinatorial approach may be the synergy exhibited by the various components, enhanced bioavailability, cumulative effects and affecting an entire network of pathways in tandem [<xref rid="B107-medicina-57-00217" ref-type="bibr">107</xref>]. </p><p>Artemisia has prominence in Chinese and Ayurvedic medicinal systems for its numerous therapeutic properties. Among the phytochemicals present in the plant, the lactone derivative artemisinin and its derivatives&#x02014;termed ARTs&#x02014;are very promising owing to their multiple pharmacological actions [<xref rid="B4-medicina-57-00217" ref-type="bibr">4</xref>,<xref rid="B7-medicina-57-00217" ref-type="bibr">7</xref>,<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B93-medicina-57-00217" ref-type="bibr">93</xref>,<xref rid="B94-medicina-57-00217" ref-type="bibr">94</xref>]. Recent studies point to ARTs as attractive candidates for SARS-CoV-2 and they are a major focus in medical research [<xref rid="B4-medicina-57-00217" ref-type="bibr">4</xref>,<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B92-medicina-57-00217" ref-type="bibr">92</xref>,<xref rid="B103-medicina-57-00217" ref-type="bibr">103</xref>]. SARS-CoV-2 infection manifests as a mild respiratory tract infection and influenza-like illness to a severe disease with accompanying lung injury (in severe cases lung fibrosis), oxidative stress, multisystem inflammatory conditions, multi-organ failure and neurological issues [<xref rid="B108-medicina-57-00217" ref-type="bibr">108</xref>,<xref rid="B109-medicina-57-00217" ref-type="bibr">109</xref>,<xref rid="B110-medicina-57-00217" ref-type="bibr">110</xref>,<xref rid="B111-medicina-57-00217" ref-type="bibr">111</xref>]. The role of ARTs as an antioxidant and anti-inflammatory and to be able to block tissues fibrosis together with its safety and low toxicity profile makes it an excellent drug candidate against SARS-CoV-2 infection [<xref rid="B85-medicina-57-00217" ref-type="bibr">85</xref>,<xref rid="B94-medicina-57-00217" ref-type="bibr">94</xref>].</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, S.G.K. and R.V.R.; Methodology, S.G.K. and R.V.R.; Data curation, S.G.K. and R.V.R.; Original draft preparation and Writing, R.V.R.; Reviewing and Editing, S.G.K. and R.V.R. Both authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>The research study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not Applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not Applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not Applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>This manuscript is not under consideration by another journal, nor has it been published. SGK is a paid consultant-at-large with Oncotelic, Inc., a wholly-owned subsidiary of Mateon Therapeutics, the sponsor for the clinical development of the proprietary formulation of ARTs for SARS-CoV-2 infection. RVR declares no competing financial interests.</p></notes><ref-list><title>References</title><ref id="B1-medicina-57-00217"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>R.V.</given-names></name><name><surname>Descamps</surname><given-names>O.</given-names></name><name><surname>John</surname><given-names>V.</given-names></name><name><surname>Bredesen</surname><given-names>D.E.</given-names></name></person-group><article-title>Ayurvedic medicinal plants for Alzheimer&#x02019;s disease: A review</article-title><source>Alzheimers Res. Ther.</source><year>2012</year><volume>4</volume><fpage>22</fpage><pub-id pub-id-type="doi">10.1186/alzrt125</pub-id><?supplied-pmid 22747839?><pub-id pub-id-type="pmid">22747839</pub-id></element-citation></ref><ref id="B2-medicina-57-00217"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parasuraman</surname><given-names>S.</given-names></name><name><surname>Thing</surname><given-names>G.S.</given-names></name><name><surname>Dhanaraj</surname><given-names>S.A.</given-names></name></person-group><article-title>Polyherbal formulation: Concept of ayurveda</article-title><source>Pharmacogn. Rev.</source><year>2014</year><volume>8</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.4103/0973-7847.134229</pub-id><pub-id pub-id-type="pmid">25125878</pub-id></element-citation></ref><ref id="B3-medicina-57-00217"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkat</surname><given-names>M.A.</given-names></name><name><surname>Goyal</surname><given-names>A.</given-names></name><name><surname>Barkat</surname><given-names>H.A.</given-names></name><name><surname>Salauddin</surname><given-names>M.</given-names></name><name><surname>Pottoo</surname><given-names>F.H.</given-names></name><name><surname>Anwer</surname><given-names>E.T.</given-names></name></person-group><article-title>Herbal medicine: Clinical perspective &#x00026; regulatory status</article-title><source>Comb. Chem. High Throughput Screen.</source><year>2020</year><pub-id pub-id-type="doi">10.2174/1386207323999201110192942</pub-id></element-citation></ref><ref id="B4-medicina-57-00217"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vellingiri</surname><given-names>B.</given-names></name><name><surname>Jayaramayya</surname><given-names>K.</given-names></name><name><surname>Iyer</surname><given-names>M.</given-names></name><name><surname>Narayanasamy</surname><given-names>A.</given-names></name><name><surname>Govindasamy</surname><given-names>V.</given-names></name><name><surname>Giridharan</surname><given-names>B.</given-names></name><name><surname>Ganesan</surname><given-names>S.</given-names></name><name><surname>Venugopal</surname><given-names>A.</given-names></name><name><surname>Venkatesan</surname><given-names>D.</given-names></name><name><surname>Ganesan</surname><given-names>H.</given-names></name><etal/></person-group><article-title>COVID-19: A promising cure for the global panic</article-title><source>Sci. Total Environ.</source><year>2020</year><volume>725</volume><fpage>138277</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138277</pub-id><pub-id pub-id-type="pmid">32278175</pub-id></element-citation></ref><ref id="B5-medicina-57-00217"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akram</surname><given-names>M.</given-names></name><name><surname>Tahir</surname><given-names>I.M.</given-names></name><name><surname>Shah</surname><given-names>S.M.A.</given-names></name><name><surname>Mahmood</surname><given-names>Z.</given-names></name><name><surname>Altaf</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>K.</given-names></name><name><surname>Munir</surname><given-names>N.</given-names></name><name><surname>Daniyal</surname><given-names>M.</given-names></name><name><surname>Nasir</surname><given-names>S.</given-names></name><name><surname>Mehboob</surname><given-names>H.</given-names></name></person-group><article-title>Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review</article-title><source>Phytother. Res.</source><year>2018</year><volume>32</volume><fpage>811</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1002/ptr.6024</pub-id><?supplied-pmid 29356205?><pub-id pub-id-type="pmid">29356205</pub-id></element-citation></ref><ref id="B6-medicina-57-00217"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>K.S.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name></person-group><article-title>The genus <italic>Artemisia</italic>: A comprehensive review</article-title><source>Pharm. Biol.</source><year>2011</year><volume>49</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.3109/13880209.2010.497815</pub-id><?supplied-pmid 20681755?><pub-id pub-id-type="pmid">20681755</pub-id></element-citation></ref><ref id="B7-medicina-57-00217"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>K.P.</given-names></name><name><surname>Sharma</surname><given-names>N.</given-names></name><name><surname>Diwaker</surname><given-names>D.</given-names></name><name><surname>Ganju</surname><given-names>L.</given-names></name><name><surname>Singh</surname><given-names>S.B.</given-names></name></person-group><article-title>Plant derived antivirals: A potential source of drug development</article-title><source>J. Virol. Antivir. Res.</source><year>2013</year><volume>2</volume><pub-id pub-id-type="doi">10.4172/2324-8955.1000109</pub-id></element-citation></ref><ref id="B8-medicina-57-00217"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koul</surname><given-names>B.</given-names></name><name><surname>Taak</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Khatri</surname><given-names>T.</given-names></name><name><surname>Sanyal</surname><given-names>I.</given-names></name></person-group><article-title>The <italic>Artemisia</italic> genus: A review on traditional uses, phytochemical constituents, pharmacological properties and germplasm conservation</article-title><source>J. Glycom. Lipidom.</source><year>2018</year><volume>7</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4172/2153-0637.1000142</pub-id></element-citation></ref><ref id="B9-medicina-57-00217"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A.K.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name></person-group><article-title>The Genus <italic>Artemisia</italic>: A 2012&#x02013;2017 literature review on chemical composition, antimicrobial, insecticidal and antioxidant activities of essential oils</article-title><source>Medicines</source><year>2017</year><volume>4</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.3390/medicines4030068</pub-id></element-citation></ref><ref id="B10-medicina-57-00217"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poiata</surname><given-names>A.</given-names></name><name><surname>Tuchilus</surname><given-names>C.</given-names></name><name><surname>Ivanescu</surname><given-names>B.</given-names></name><name><surname>Ionescu</surname><given-names>A.</given-names></name><name><surname>Lazar</surname><given-names>M.I.</given-names></name></person-group><article-title>Antibacterial activity of some <italic>Artemisia</italic> species extract</article-title><source>Revista Medico Chirurgicala a Societatii de Medici si Naturalisti din Iasi</source><year>2009</year><volume>113</volume><fpage>911</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">20191854</pub-id></element-citation></ref><ref id="B11-medicina-57-00217"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>R.X.</given-names></name><name><surname>Zheng</surname><given-names>W.F.</given-names></name><name><surname>Tang</surname><given-names>H.Q.</given-names></name></person-group><article-title>Biologically active substances from the genus <italic>Artemisia</italic></article-title><source>Planta Medica</source><year>1998</year><volume>64</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1055/s-2006-957438</pub-id><pub-id pub-id-type="pmid">9619108</pub-id></element-citation></ref><ref id="B12-medicina-57-00217"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obistioiu</surname><given-names>D.</given-names></name><name><surname>Cristina</surname><given-names>R.T.</given-names></name><name><surname>Schmerold</surname><given-names>I.</given-names></name><name><surname>Chizzola</surname><given-names>R.</given-names></name><name><surname>Stolze</surname><given-names>K.</given-names></name><name><surname>Nichita</surname><given-names>I.</given-names></name><name><surname>Chiurciu</surname><given-names>V.</given-names></name></person-group><article-title>Chemical characterization by GC-MS and in vitro activity against <italic>Candida albicans</italic> of volatile fractions prepared from <italic>Artemisia dracunculus</italic>, <italic>Artemisia abrotanum</italic>, <italic>Artemisia absinthium</italic> and <italic>Artemisia vulgaris</italic></article-title><source>Chem. Cent. J.</source><year>2014</year><volume>8</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/1752-153X-8-6</pub-id><?supplied-pmid 24475951?><pub-id pub-id-type="pmid">24475951</pub-id></element-citation></ref><ref id="B13-medicina-57-00217"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semwal</surname><given-names>B.R.</given-names></name><name><surname>Semwal</surname><given-names>D.K.</given-names></name><name><surname>Mishra</surname><given-names>S.P.</given-names></name><name><surname>Semwal</surname><given-names>R.</given-names></name></person-group><article-title>Chemical composition and antibacterial potential of essential oils from <italic>Artemisia capillaris</italic>, <italic>Artemisia nilagirica</italic>, <italic>Citrus limon</italic>, <italic>Cymbopogon flexuosus</italic>, <italic>Hedychium spicatum</italic> and <italic>Ocimum tenuiflorum</italic></article-title><source>Nat. Prod. J.</source><year>2015</year><volume>5</volume><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.2174/2210315505666150827213344</pub-id></element-citation></ref><ref id="B14-medicina-57-00217"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoine</surname><given-names>T.</given-names></name><name><surname>Fisher</surname><given-names>N.</given-names></name><name><surname>Amewu</surname><given-names>R.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>P.M.</given-names></name><name><surname>Ward</surname><given-names>S.A.</given-names></name><name><surname>Biagini</surname><given-names>G.A.</given-names></name></person-group><article-title>Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential</article-title><source>J. Antimicrob. Chemother.</source><year>2014</year><volume>69</volume><fpage>1005</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1093/jac/dkt486</pub-id><pub-id pub-id-type="pmid">24335485</pub-id></element-citation></ref><ref id="B15-medicina-57-00217"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>N.K.</given-names></name><name><surname>Tyagi</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>S.K.</given-names></name></person-group><article-title>The impact of artemisinin combination therapy and long-lasting insecticidal nets on forest malaria incidence in tribal villages of India, 2006&#x02013;2011</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e56740</elocation-id><pub-id pub-id-type="doi">10.1371/annotation/2adc258d-3eb2-4bb9-b8a9-b37ff76c6c62</pub-id><pub-id pub-id-type="pmid">23437229</pub-id></element-citation></ref><ref id="B16-medicina-57-00217"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>WWARN Artemisinin Based Combination Therapy (ACT) Africa Baseline Study Group</collab></person-group><article-title>Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: A literature review and meta-analysis of individual patient data</article-title><source>BMC Med.</source><year>2015</year><volume>13</volume><elocation-id>212</elocation-id><pub-id pub-id-type="pmid">26343145</pub-id></element-citation></ref><ref id="B17-medicina-57-00217"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tambo</surname><given-names>E.</given-names></name><name><surname>Khater</surname><given-names>E.I.</given-names></name><name><surname>Chen</surname><given-names>J.H.</given-names></name><name><surname>Bergquist</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>X.N.</given-names></name></person-group><article-title>Nobel prize for the artemisinin and ivermectin discoveries: A great boost towards elimination of the global infectious diseases of poverty</article-title><source>Infect. Dis. Poverty</source><year>2015</year><volume>4</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s40249-015-0091-8</pub-id><pub-id pub-id-type="pmid">26708575</pub-id></element-citation></ref><ref id="B18-medicina-57-00217"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>X.Z.</given-names></name><name><surname>Miller</surname><given-names>L.H.</given-names></name></person-group><article-title>The discovery of artemisinin and the Nobel prize in physiology or medicine</article-title><source>Sci. China Life Sci.</source><year>2015</year><volume>58</volume><fpage>1175</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.1007/s11427-015-4948-7</pub-id><pub-id pub-id-type="pmid">26481135</pub-id></element-citation></ref><ref id="B19-medicina-57-00217"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>R.K.</given-names></name><name><surname>Satyal</surname><given-names>P.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Himalayan aromatic medicinal plants: A review of their ethnopharmacology, volatile phytochemistry, and biological activities</article-title><source>Medicines</source><year>2016</year><volume>3</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3390/medicines3010006</pub-id></element-citation></ref><ref id="B20-medicina-57-00217"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>V.K.</given-names></name><name><surname>Joshi</surname><given-names>A.</given-names></name><name><surname>Dhiman</surname><given-names>K.S.</given-names></name></person-group><article-title>The ayurvedic pharmacopoeia of India, development and perspectives</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>197</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.07.030</pub-id><pub-id pub-id-type="pmid">27404231</pub-id></element-citation></ref><ref id="B21-medicina-57-00217"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Arya</surname><given-names>V.</given-names></name><name><surname>Kaur</surname><given-names>R.</given-names></name><name><surname>Bhat</surname><given-names>Z.A.</given-names></name><name><surname>Gupta</surname><given-names>V.K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><article-title>A review of immunomodulators in the Indian traditional health care system</article-title><source>J. Microbiol. Immunol. Infect.</source><year>2012</year><volume>45</volume><fpage>165</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2011.09.030</pub-id><?supplied-pmid 22154993?><pub-id pub-id-type="pmid">22154993</pub-id></element-citation></ref><ref id="B22-medicina-57-00217"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katiyar</surname><given-names>C.K.</given-names></name></person-group><article-title>Ayurpathy: A modern perspective of Ayurveda</article-title><source>Ayu</source><year>2011</year><volume>32</volume><fpage>304</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.4103/0974-8520.93903</pub-id><pub-id pub-id-type="pmid">22529640</pub-id></element-citation></ref><ref id="B23-medicina-57-00217"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanescu</surname><given-names>B.</given-names></name><name><surname>Miron</surname><given-names>A.</given-names></name><name><surname>Corciova</surname><given-names>A.</given-names></name></person-group><article-title>Sesquiterpene lactones from <italic>Artemisia</italic> genus: Biological activities and methods of analysis</article-title><source>J. Anal. Methods Chem.</source><year>2015</year><volume>2015</volume><pub-id pub-id-type="doi">10.1155/2015/247685</pub-id></element-citation></ref><ref id="B24-medicina-57-00217"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batiha</surname><given-names>G.E.</given-names></name><name><surname>Olatunde</surname><given-names>A.</given-names></name><name><surname>El-Mleeh</surname><given-names>A.</given-names></name><name><surname>Hetta</surname><given-names>H.F.</given-names></name><name><surname>Al-Rejaie</surname><given-names>S.</given-names></name><name><surname>Alghamdi</surname><given-names>S.</given-names></name><name><surname>Zahoor</surname><given-names>M.</given-names></name><name><surname>Magdy Beshbishy</surname><given-names>A.</given-names></name><name><surname>Murata</surname><given-names>T.</given-names></name><name><surname>Zaragoza-Bastida</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Bioactive compounds, pharmacological actions, and pharmacokinetics of wormwood (<italic>Artemisia absinthium</italic>)</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>353</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9060353</pub-id></element-citation></ref><ref id="B25-medicina-57-00217"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Kumari</surname><given-names>R.</given-names></name></person-group><article-title><italic>Artemisia</italic>: A medicinally important genus</article-title><source>J. Complement. Med. Alt. Healthcare</source><year>2018</year><volume>7</volume><pub-id pub-id-type="doi">10.19080/JCMAH.2018.07.555723</pub-id></element-citation></ref><ref id="B26-medicina-57-00217"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N.Q.</given-names></name><name><surname>Van der Kooy</surname><given-names>F.</given-names></name><name><surname>Verpoorte</surname><given-names>R.</given-names></name></person-group><article-title><italic>Artemisia afra</italic>: A potential flagship for African medicinal plants?</article-title><source>South Afr. J. Bot.</source><year>2009</year><volume>75</volume><fpage>185</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2008.11.001</pub-id></element-citation></ref><ref id="B27-medicina-57-00217"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Qiu</surname><given-names>F.</given-names></name></person-group><article-title>Phytochemical analysis and geographic assessment of flavonoids, coumarins and sesquiterpenes in <italic>Artemisia annua</italic> L. based on HPLC-DAD quantification and LC-ESI-QTOF-MS/MS confirmation</article-title><source>Food Chem.</source><year>2020</year><volume>312</volume><fpage>126070</fpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2019.126070</pub-id><?supplied-pmid 31911352?><pub-id pub-id-type="pmid">31911352</pub-id></element-citation></ref><ref id="B28-medicina-57-00217"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>S.</given-names></name><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name></person-group><article-title>Traditional application and modern pharmacological research of <italic>Artemisia annua</italic> L.</article-title><source>Pharmacol. Ther.</source><year>2020</year><volume>216</volume><fpage>107650</fpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2020.107650</pub-id><?supplied-pmid 32758647?><pub-id pub-id-type="pmid">32758647</pub-id></element-citation></ref><ref id="B29-medicina-57-00217"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Septembre-Malaterre</surname><given-names>A.</given-names></name><name><surname>Lalarizo Rakoto</surname><given-names>M.</given-names></name><name><surname>Marodon</surname><given-names>C.</given-names></name><name><surname>Bedoui</surname><given-names>Y.</given-names></name><name><surname>Nakab</surname><given-names>J.</given-names></name><name><surname>Simon</surname><given-names>E.</given-names></name><name><surname>Hoarau</surname><given-names>L.</given-names></name><name><surname>Savriama</surname><given-names>S.</given-names></name><name><surname>Strasberg</surname><given-names>D.</given-names></name><name><surname>Guiraud</surname><given-names>P.</given-names></name><etal/></person-group><article-title><italic>Artemisia annua</italic>, a traditional plant brought to light</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4986</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21144986</pub-id><?supplied-pmid 32679734?><pub-id pub-id-type="pmid">32679734</pub-id></element-citation></ref><ref id="B30-medicina-57-00217"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahuja</surname><given-names>A.</given-names></name><name><surname>Yi</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>M.Y.</given-names></name><name><surname>Cho</surname><given-names>J.Y.</given-names></name></person-group><article-title>Ethnopharmacological properties of <italic>Artemisia asiatica</italic>: A comprehensive review</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>220</volume><fpage>117</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.03.032</pub-id><pub-id pub-id-type="pmid">29604379</pub-id></element-citation></ref><ref id="B31-medicina-57-00217"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>R.</given-names></name><name><surname>Ragusa</surname><given-names>S.</given-names></name><name><surname>Russo</surname><given-names>M.</given-names></name><name><surname>Certo</surname><given-names>G.</given-names></name><name><surname>Franchina</surname><given-names>F.A.</given-names></name><name><surname>Zanotto</surname><given-names>A.</given-names></name><name><surname>Grasso</surname><given-names>E.</given-names></name><name><surname>Mondello</surname><given-names>L.</given-names></name><name><surname>Germano</surname><given-names>M.P.</given-names></name></person-group><article-title>Phytochemical screening of <italic>Artemisia arborescens</italic> L. by means of advanced chromatographic techniques for identification of health-promoting compounds</article-title><source>J. Pharm. Biomed. Anal.</source><year>2016</year><volume>117</volume><fpage>499</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2015.10.006</pub-id><pub-id pub-id-type="pmid">26476295</pub-id></element-citation></ref><ref id="B32-medicina-57-00217"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>J.D.</given-names></name><name><surname>Garcia</surname><given-names>C.</given-names></name><name><surname>Garg</surname><given-names>G.</given-names></name></person-group><article-title>Mugwort (<italic>Artemisia vulgaris</italic>, <italic>Artemisia douglasiana</italic>, <italic>Artemisia argyi</italic>) in the treatment of menopause, premenstrual syndrome, dysmenorrhea and Attention Deficit Hyperactivity Disorder</article-title><source>Chin. Med.</source><year>2012</year><volume>3</volume><fpage>116</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.4236/cm.2012.33019</pub-id></element-citation></ref><ref id="B33-medicina-57-00217"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allerton</surname><given-names>T.D.</given-names></name><name><surname>Kowalski</surname><given-names>G.M.</given-names></name><name><surname>Stampley</surname><given-names>J.</given-names></name><name><surname>Irving</surname><given-names>B.A.</given-names></name><name><surname>Lighton</surname><given-names>J.R.B.</given-names></name><name><surname>Floyd</surname><given-names>Z.E.</given-names></name><name><surname>Stephens</surname><given-names>J.M.</given-names></name></person-group><article-title>An ethanolic extract of <italic>Artemisia dracunculus</italic> L. enhances the metabolic benefits of exercise in diet-induced obese mice</article-title><source>Med. Sci. Sports Exerc.</source><year>2020</year><pub-id pub-id-type="doi">10.1249/MSS.0000000000002516</pub-id><?supplied-pmid 33105388?><pub-id pub-id-type="pmid">33105388</pub-id></element-citation></ref><ref id="B34-medicina-57-00217"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majdan</surname><given-names>M.</given-names></name><name><surname>Kiss</surname><given-names>A.K.</given-names></name><name><surname>Halasa</surname><given-names>R.</given-names></name><name><surname>Granica</surname><given-names>S.</given-names></name><name><surname>Osinska</surname><given-names>E.</given-names></name><name><surname>Czerwinska</surname><given-names>M.E.</given-names></name></person-group><article-title>Inhibition of neutrophil functions and antibacterial effects of tarragon (<italic>Artemisia dracunculus</italic> L.) infusion-phytochemical characterization</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.3389/fphar.2020.00947</pub-id></element-citation></ref><ref id="B35-medicina-57-00217"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokhtar</surname><given-names>A.B.</given-names></name><name><surname>Ahmed</surname><given-names>S.A.</given-names></name><name><surname>Eltamany</surname><given-names>E.E.</given-names></name><name><surname>Karanis</surname><given-names>P.</given-names></name></person-group><article-title>Anti-blastocystis activity in vitro of Egyptian herbal extracts (family: Asteraceae) with emphasis on <italic>Artemisia judaica</italic></article-title><source>Int. J. Environ. Res. Public Health</source><year>2019</year><volume>16</volume><elocation-id>1555</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph16091555</pub-id></element-citation></ref><ref id="B36-medicina-57-00217"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.Y.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Hwang</surname><given-names>D.Y.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Moon</surname><given-names>J.H.</given-names></name><name><surname>Ju Lee</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>K.D.</given-names></name><name><surname>Ham</surname><given-names>K.S.</given-names></name></person-group><article-title>Three new decenynol glucosides from <italic>Artemisia scoparia</italic> (Asteraceae)</article-title><source>J. Asian Nat. Prod. Res.</source><year>2020</year><volume>22</volume><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1080/10286020.2019.1646729</pub-id><?supplied-pmid 31359770?><pub-id pub-id-type="pmid">31359770</pub-id></element-citation></ref><ref id="B37-medicina-57-00217"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>A.</given-names></name><name><surname>Poulev</surname><given-names>A.</given-names></name><name><surname>Ribnicky</surname><given-names>D.M.</given-names></name><name><surname>Raskin</surname><given-names>I.</given-names></name><name><surname>Rathinasabapathy</surname><given-names>T.</given-names></name><name><surname>Richard</surname><given-names>A.J.</given-names></name><name><surname>Stephens</surname><given-names>J.M.</given-names></name></person-group><article-title>Distinct fractions of an <italic>Artemisia scoparia</italic> extract contain compounds with novel adipogenic bioactivity</article-title><source>Front. Nutr.</source><year>2019</year><volume>6</volume><pub-id pub-id-type="doi">10.3389/fnut.2019.00018</pub-id></element-citation></ref><ref id="B38-medicina-57-00217"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Siemsen</surname><given-names>D.W.</given-names></name><name><surname>Kirpotina</surname><given-names>L.N.</given-names></name><name><surname>Wiley</surname><given-names>J.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>Fractionation and characterization of biologically-active polysaccharides from <italic>Artemisia tripartita</italic></article-title><source>Phytochemistry</source><year>2008</year><volume>69</volume><fpage>1359</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2008.01.009</pub-id><?supplied-pmid 18325553?><pub-id pub-id-type="pmid">18325553</pub-id></element-citation></ref><ref id="B39-medicina-57-00217"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calderone</surname><given-names>V.</given-names></name><name><surname>Martinotti</surname><given-names>E.</given-names></name><name><surname>Baragatti</surname><given-names>B.</given-names></name><name><surname>Breschi</surname><given-names>M.C.</given-names></name><name><surname>Morelli</surname><given-names>I.</given-names></name></person-group><article-title>Vascular effects of aqueous crude extracts of <italic>Artemisia verlotorum</italic> Lamotte (Compositae): In vivo and in vitro pharmacological studies in rats</article-title><source>Phytother. Res.</source><year>1999</year><volume>13</volume><fpage>645</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1573(199912)13:8&#x0003c;645::AID-PTR496&#x0003e;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10594931</pub-id></element-citation></ref><ref id="B40-medicina-57-00217"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Lima</surname><given-names>T.C.</given-names></name><name><surname>Morato</surname><given-names>G.S.</given-names></name><name><surname>Takahashi</surname><given-names>R.N.</given-names></name></person-group><article-title>Evaluation of the central properties of <italic>Artemisia verlotorum</italic></article-title><source>Planta Medica</source><year>1993</year><volume>59</volume><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1055/s-2006-959692</pub-id><pub-id pub-id-type="pmid">8372149</pub-id></element-citation></ref><ref id="B41-medicina-57-00217"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y.H.</given-names></name><name><surname>Wang</surname><given-names>H.T.</given-names></name><name><surname>Shi</surname><given-names>S.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>J.C.</given-names></name><name><surname>Wu</surname><given-names>H.B.</given-names></name></person-group><article-title>Sesquiterpenoids from <italic>Artemisia vestita</italic> and their antifeedant and antifungal activities</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>3671</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24203671</pub-id></element-citation></ref><ref id="B42-medicina-57-00217"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>S.H.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Zeng</surname><given-names>K.W.</given-names></name><name><surname>Zhao</surname><given-names>M.B.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Tu</surname><given-names>P.F.</given-names></name></person-group><article-title>Sesquiterpenoids from <italic>Artemisia vestita</italic></article-title><source>Phytochmistry</source><year>2018</year><volume>147</volume><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2018.01.004</pub-id><?supplied-pmid 29353156?><pub-id pub-id-type="pmid">29353156</pub-id></element-citation></ref><ref id="B43-medicina-57-00217"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragasa</surname><given-names>C.Y.</given-names></name><name><surname>de Jesus</surname><given-names>J.P.</given-names></name><name><surname>Apuada</surname><given-names>M.J.</given-names></name><name><surname>Rideout</surname><given-names>J.A.</given-names></name></person-group><article-title>A new sesquiterpene from <italic>Artemisia vulgaris</italic></article-title><source>J. Nat. Med.</source><year>2008</year><volume>62</volume><fpage>461</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1007/s11418-008-0253-0</pub-id><pub-id pub-id-type="pmid">18438634</pub-id></element-citation></ref><ref id="B44-medicina-57-00217"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willcox</surname><given-names>M.</given-names></name></person-group><article-title><italic>Artemisia</italic> species: From traditional medicines to modern antimalarials&#x02014;And back again</article-title><source>J. Altern. Complement. Med.</source><year>2009</year><volume>15</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1089/acm.2008.0327</pub-id><?supplied-pmid 19236169?><pub-id pub-id-type="pmid">19236169</pub-id></element-citation></ref><ref id="B45-medicina-57-00217"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nigam</surname><given-names>M.</given-names></name><name><surname>Atanassova</surname><given-names>M.</given-names></name><name><surname>Mishra</surname><given-names>A.P.</given-names></name><name><surname>Pezzani</surname><given-names>R.</given-names></name><name><surname>Devkota</surname><given-names>H.P.</given-names></name><name><surname>Plygun</surname><given-names>S.</given-names></name><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name></person-group><article-title>Bioactive compounds and health benefits of <italic>Artemisia</italic> species</article-title><source>Nat. Prod. Commun.</source><year>2019</year><pub-id pub-id-type="doi">10.1177/1934578X19850354</pub-id></element-citation></ref><ref id="B46-medicina-57-00217"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekiert</surname><given-names>H.</given-names></name><name><surname>Pajor</surname><given-names>J.</given-names></name><name><surname>Klin</surname><given-names>P.</given-names></name><name><surname>Rzepiela</surname><given-names>A.</given-names></name><name><surname>Slesak</surname><given-names>H.</given-names></name><name><surname>Szopa</surname><given-names>A.</given-names></name></person-group><article-title>Significance of <italic>Artemisia vulgaris</italic>, L. (common mugwort) in the history of medicine and its possible contemporary applications substantiated by phytochemical and pharmacological studies</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>4415</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25194415</pub-id></element-citation></ref><ref id="B47-medicina-57-00217"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abad</surname><given-names>M.J.</given-names></name><name><surname>Bedoya</surname><given-names>L.M.</given-names></name><name><surname>Apaza</surname><given-names>L.</given-names></name><name><surname>Bermejo</surname><given-names>P.</given-names></name></person-group><article-title>The <italic>Artemisia</italic> L. genus: A review of bioactive essential oils</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>2542</fpage><lpage>2566</lpage><pub-id pub-id-type="doi">10.3390/molecules17032542</pub-id><?supplied-pmid 22388966?><pub-id pub-id-type="pmid">22388966</pub-id></element-citation></ref><ref id="B48-medicina-57-00217"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Thiruvengadam</surname><given-names>M.</given-names></name><name><surname>Ching</surname><given-names>I.M.</given-names></name><name><surname>Nagella</surname><given-names>P.</given-names></name></person-group><article-title>Polyphenol composition and antioxidant activity from the vegetable plant <italic>Artemisia absinthium</italic> L.</article-title><source>Aust. J. Crop Sci.</source><year>2013</year><volume>7</volume><fpage>1921</fpage><lpage>1926</lpage></element-citation></ref><ref id="B49-medicina-57-00217"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiani</surname><given-names>B.H.</given-names></name><name><surname>Kayani</surname><given-names>W.K.</given-names></name><name><surname>Khayam</surname><given-names>A.U.</given-names></name><name><surname>Dilshad</surname><given-names>E.</given-names></name><name><surname>Ismail</surname><given-names>H.</given-names></name><name><surname>Mirza</surname><given-names>B.</given-names></name></person-group><article-title>Artemisinin and its derivatives: A promising cancer therapy</article-title><source>Mol. Biol. Rep.</source><year>2020</year><volume>47</volume><fpage>6321</fpage><lpage>6336</lpage><pub-id pub-id-type="doi">10.1007/s11033-020-05669-z</pub-id><pub-id pub-id-type="pmid">32710388</pub-id></element-citation></ref><ref id="B50-medicina-57-00217"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firestone</surname><given-names>G.L.</given-names></name><name><surname>Sundar</surname><given-names>S.N.</given-names></name></person-group><article-title>Anticancer activities of artemisinin and its bioactive derivatives</article-title><source>Expert Rev. Mol. Med.</source><year>2009</year><volume>11</volume><pub-id pub-id-type="doi">10.1017/S1462399409001239</pub-id></element-citation></ref><ref id="B51-medicina-57-00217"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname><given-names>B.T.K.</given-names></name><name><surname>Ly</surname><given-names>D.M.</given-names></name><name><surname>Linh</surname><given-names>P.H.</given-names></name><name><surname>Son</surname><given-names>H.K.</given-names></name><name><surname>Ha</surname><given-names>N.L.</given-names></name><name><surname>Chi</surname><given-names>H.T.</given-names></name></person-group><article-title>Screening of medicinal herbs for cytotoxic activity to leukemia cells</article-title><source>J. BUON</source><year>2020</year><volume>25</volume><fpage>1989</fpage><lpage>1996</lpage><pub-id pub-id-type="pmid">33099943</pub-id></element-citation></ref><ref id="B52-medicina-57-00217"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.S.</given-names></name><name><surname>Yadav</surname><given-names>T.T.</given-names></name><name><surname>Khair</surname><given-names>R.R.</given-names></name><name><surname>Peters</surname><given-names>G.J.</given-names></name><name><surname>Yergeri</surname><given-names>M.C.</given-names></name></person-group><article-title>Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment</article-title><source>Curr. Pharm. Des.</source><year>2019</year><volume>25</volume><fpage>3323</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.2174/1381612825666190902155957</pub-id><?supplied-pmid 31475891?><pub-id pub-id-type="pmid">31475891</pub-id></element-citation></ref><ref id="B53-medicina-57-00217"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>Q.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Pi</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name></person-group><article-title>Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 signaling</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0147157</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0147157</pub-id><?supplied-pmid 26784960?><pub-id pub-id-type="pmid">26784960</pub-id></element-citation></ref><ref id="B54-medicina-57-00217"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slezakova</surname><given-names>S.</given-names></name><name><surname>Ruda-Kucerova</surname><given-names>J.</given-names></name></person-group><article-title>Anticancer activity of artemisinin and its derivatives</article-title><source>Anticancer Res.</source><year>2017</year><volume>37</volume><fpage>5995</fpage><lpage>6003</lpage><pub-id pub-id-type="pmid">29061778</pub-id></element-citation></ref><ref id="B55-medicina-57-00217"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulito</surname><given-names>C.</given-names></name><name><surname>Strano</surname><given-names>S.</given-names></name><name><surname>Blandino</surname><given-names>G.</given-names></name></person-group><article-title>Dihydroartemisinin: From malaria to the treatment of relapsing head and neck cancers</article-title><source>Ann. Transl. Med.</source><year>2020</year><volume>8</volume><fpage>612</fpage><pub-id pub-id-type="doi">10.21037/atm.2020.03.104</pub-id><?supplied-pmid 32566549?><pub-id pub-id-type="pmid">32566549</pub-id></element-citation></ref><ref id="B56-medicina-57-00217"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>S.</given-names></name><name><surname>Ganapathi</surname><given-names>S.</given-names></name><name><surname>Ster</surname><given-names>I.C.</given-names></name><name><surname>Saeed</surname><given-names>M.E.</given-names></name><name><surname>Cowan</surname><given-names>M.</given-names></name><name><surname>Finlayson</surname><given-names>C.</given-names></name><name><surname>Kovacsevics</surname><given-names>H.</given-names></name><name><surname>Jansen</surname><given-names>H.</given-names></name><name><surname>Kremsner</surname><given-names>P.G.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><etal/></person-group><article-title>A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer</article-title><source>EBioMedicine</source><year>2015</year><volume>2</volume><fpage>82</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2014.11.010</pub-id><?supplied-pmid 26137537?><pub-id pub-id-type="pmid">26137537</pub-id></element-citation></ref><ref id="B57-medicina-57-00217"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>T.G.</given-names></name><name><surname>Dieckmann</surname><given-names>D.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Schultz</surname><given-names>E.S.</given-names></name><name><surname>Funk</surname><given-names>J.O.</given-names></name><name><surname>Baur</surname><given-names>A.</given-names></name><name><surname>Schuler</surname><given-names>G.</given-names></name></person-group><article-title>Artesunate in the treatment of metastatic uveal melanoma&#x02014;First experiences</article-title><source>Oncol. Rep.</source><year>2005</year><volume>14</volume><fpage>1599</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.3892/or.14.6.1599</pub-id><?supplied-pmid 16273263?><pub-id pub-id-type="pmid">16273263</pub-id></element-citation></ref><ref id="B58-medicina-57-00217"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Xing</surname><given-names>Y.Q.</given-names></name></person-group><article-title>Eupatilin prevents H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and apoptosis in human retinal pigment epithelial cells</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>85</volume><fpage>136</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.11.108</pub-id><pub-id pub-id-type="pmid">27930977</pub-id></element-citation></ref><ref id="B59-medicina-57-00217"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>S.</given-names></name><name><surname>Uhlemann</surname><given-names>A.C.</given-names></name><name><surname>Haynes</surname><given-names>R.K.</given-names></name></person-group><article-title>Artemisinins: Mechanisms of action and potential for resistance</article-title><source>Drug Resist. Updates</source><year>2004</year><volume>7</volume><fpage>233</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.drup.2004.07.001</pub-id></element-citation></ref><ref id="B60-medicina-57-00217"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M.T.</given-names></name><name><surname>Kuo</surname><given-names>T.F.</given-names></name><name><surname>Chung</surname><given-names>K.F.</given-names></name><name><surname>Liang</surname><given-names>Y.C.</given-names></name><name><surname>Yang</surname><given-names>C.W.</given-names></name><name><surname>Lin</surname><given-names>C.Y.</given-names></name><name><surname>Feng</surname><given-names>C.S.</given-names></name><name><surname>Chen</surname><given-names>Z.W.</given-names></name><name><surname>Lee</surname><given-names>T.H.</given-names></name><name><surname>Hsiao</surname><given-names>C.L.</given-names></name><etal/></person-group><article-title>Authentication, phytochemical characterization and anti-bacterial activity of two <italic>Artemisia</italic> species</article-title><source>Food Chem.</source><year>2020</year><volume>333</volume><fpage>127458</fpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2020.127458</pub-id><?supplied-pmid 32673952?><pub-id pub-id-type="pmid">32673952</pub-id></element-citation></ref><ref id="B61-medicina-57-00217"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Qian</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>Antibacterial activity of <italic>Artemisia asiatica</italic> essential oil against some common respiratory infection causing bacterial strains and its mechanism of action in <italic>Haemophilus influenzae</italic></article-title><source>Microb. Pathog.</source><year>2018</year><volume>114</volume><fpage>470</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.12.032</pub-id><pub-id pub-id-type="pmid">29241769</pub-id></element-citation></ref><ref id="B62-medicina-57-00217"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Su</surname><given-names>X.Z.</given-names></name></person-group><article-title>Discovery, mechanisms of action and combination therapy of artemisinin</article-title><source>Expert Rev. Anti Infect. Ther.</source><year>2009</year><volume>7</volume><fpage>999</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1586/eri.09.68</pub-id><pub-id pub-id-type="pmid">19803708</pub-id></element-citation></ref><ref id="B63-medicina-57-00217"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolivo</surname><given-names>D.</given-names></name><name><surname>Weathers</surname><given-names>P.</given-names></name><name><surname>Dominko</surname><given-names>T.</given-names></name></person-group><article-title>Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics</article-title><source>Acta Pharmaceutica Sinica B</source><year>2021</year><volume>11</volume><fpage>322</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2020.09.001</pub-id><pub-id pub-id-type="pmid">33643815</pub-id></element-citation></ref><ref id="B64-medicina-57-00217"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>You</surname><given-names>F.</given-names></name><name><surname>Xue</surname><given-names>J.</given-names></name></person-group><article-title>Novel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis</article-title><source>Pharmacol. Res.</source><year>2020</year><volume>157</volume><fpage>104829</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2020.104829</pub-id><?supplied-pmid 32360483?><pub-id pub-id-type="pmid">32360483</pub-id></element-citation></ref><ref id="B65-medicina-57-00217"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B.W.</given-names></name><name><surname>Baum</surname><given-names>L.</given-names></name><name><surname>So</surname><given-names>K.F.</given-names></name><name><surname>Chiu</surname><given-names>K.</given-names></name><name><surname>Xie</surname><given-names>L.K.</given-names></name></person-group><article-title>More than anti-malarial agents: Therapeutic potential of artemisinins in neurodegeneration</article-title><source>Neural Regen. Res.</source><year>2019</year><volume>14</volume><fpage>1494</fpage><lpage>1498</lpage><pub-id pub-id-type="pmid">31089038</pub-id></element-citation></ref><ref id="B66-medicina-57-00217"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajjad</surname><given-names>N.</given-names></name><name><surname>Wani</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>R.</given-names></name><name><surname>Hassan</surname><given-names>S.</given-names></name><name><surname>Hamid</surname><given-names>R.</given-names></name><name><surname>Habib</surname><given-names>H.</given-names></name><name><surname>Ganai</surname><given-names>B.A.</given-names></name></person-group><article-title><italic>Artemisia amygdalina</italic> upregulates Nrf2 and protects neurons against oxidative stress in Alzheimer disease</article-title><source>Cell Mol. Neurobiol.</source><year>2019</year><volume>39</volume><fpage>387</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1007/s10571-019-00656-w</pub-id><pub-id pub-id-type="pmid">30725250</pub-id></element-citation></ref><ref id="B67-medicina-57-00217"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiang</surname><given-names>W.</given-names></name><name><surname>Cai</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Yin</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation</article-title><source>Neuroscience</source><year>2018</year><volume>395</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.10.041</pub-id><pub-id pub-id-type="pmid">30399421</pub-id></element-citation></ref><ref id="B68-medicina-57-00217"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Long</surname><given-names>Z.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Feng</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Dihydroartemisinin ameliorates learning and memory in Alzheimer&#x02019;s disease through promoting autophagosome-lysosome fusion and autolysosomal degradation for abeta clearance</article-title><source>Front. Aging Neurosci.</source><year>2020</year><volume>12</volume><pub-id pub-id-type="doi">10.3389/fnagi.2020.00047</pub-id><?supplied-pmid 32210783?><pub-id pub-id-type="pmid">32210783</pub-id></element-citation></ref><ref id="B69-medicina-57-00217"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bredesen</surname><given-names>D.E.</given-names></name></person-group><article-title>Inhalational Alzheimer&#x02019;s disease: An unrecognized&#x02014;And treatable&#x02014;Epidemic</article-title><source>Aging</source><year>2016</year><volume>8</volume><fpage>304</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.18632/aging.100896</pub-id><?supplied-pmid 26870879?><pub-id pub-id-type="pmid">26870879</pub-id></element-citation></ref><ref id="B70-medicina-57-00217"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bredesen</surname><given-names>D.E.</given-names></name><name><surname>Rao</surname><given-names>R.V.</given-names></name></person-group><article-title>Ayurvedic profiling of Alzheimer&#x02019;s disease</article-title><source>Altern. Ther. Health Med.</source><year>2017</year><volume>23</volume><fpage>46</fpage><lpage>50</lpage><?supplied-pmid 28236613?><pub-id pub-id-type="pmid">28236613</pub-id></element-citation></ref><ref id="B71-medicina-57-00217"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>L.</given-names></name></person-group><article-title>Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives</article-title><source>Mediators Inflamm.</source><year>2015</year><volume>2015</volume><pub-id pub-id-type="doi">10.1155/2015/435713</pub-id><?supplied-pmid 25960615?><pub-id pub-id-type="pmid">25960615</pub-id></element-citation></ref><ref id="B72-medicina-57-00217"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>D.P.</given-names></name><name><surname>Li</surname><given-names>H.B.</given-names></name><name><surname>Pang</surname><given-names>Q.Q.</given-names></name><name><surname>Huang</surname><given-names>Y.X.</given-names></name><name><surname>Pan</surname><given-names>D.B.</given-names></name><name><surname>Su</surname><given-names>Z.Z.</given-names></name><name><surname>Yao</surname><given-names>X.J.</given-names></name><name><surname>Yao</surname><given-names>X.S.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name></person-group><article-title>Structurally diverse sesquiterpenoids from the aerial parts of <italic>Artemisia annua</italic> (Qinghao) and their striking systemically anti-inflammatory activities</article-title><source>Bioorg. Chem.</source><year>2020</year><volume>103</volume><fpage>104221</fpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104221</pub-id><pub-id pub-id-type="pmid">32891001</pub-id></element-citation></ref><ref id="B73-medicina-57-00217"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>A.</given-names></name><name><surname>Burke</surname><given-names>S.J.</given-names></name><name><surname>Collier</surname><given-names>J.J.</given-names></name><name><surname>Richard</surname><given-names>A.J.</given-names></name><name><surname>Ribnicky</surname><given-names>D.M.</given-names></name><name><surname>Stephens</surname><given-names>J.M.</given-names></name></person-group><article-title>Mechanisms of <italic>Artemisia scoparia</italic>&#x02019;s anti-inflammatory activity in cultured adipocytes, macrophages, and pancreatic &#x003b2;-cells</article-title><source>Obesity</source><year>2020</year><volume>28</volume><fpage>1726</fpage><lpage>1735</lpage><pub-id pub-id-type="doi">10.1002/oby.22912</pub-id><pub-id pub-id-type="pmid">32741148</pub-id></element-citation></ref><ref id="B74-medicina-57-00217"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamani</surname><given-names>S.</given-names></name><name><surname>Emami</surname><given-names>S.A.</given-names></name><name><surname>Iranshahi</surname><given-names>M.</given-names></name><name><surname>Zamani Taghizadeh Rabe</surname><given-names>S.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name></person-group><article-title>Sesquiterpene fractions of <italic>Artemisia</italic> plants as potent inhibitors of inducible nitric oxide synthase and cyclooxygenase-2 expression</article-title><source>Iran. J. Basic Med. Sci.</source><year>2019</year><volume>22</volume><fpage>774</fpage><lpage>780</lpage><?supplied-pmid 32373299?><pub-id pub-id-type="pmid">32373299</pub-id></element-citation></ref><ref id="B75-medicina-57-00217"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Ho</surname><given-names>W.E.</given-names></name><name><surname>Goh</surname><given-names>F.Y.</given-names></name><name><surname>Guan</surname><given-names>S.P.</given-names></name><name><surname>Kong</surname><given-names>L.R.</given-names></name><name><surname>Lai</surname><given-names>W.Q.</given-names></name><name><surname>Leung</surname><given-names>B.P.</given-names></name><name><surname>Wong</surname><given-names>W.S.</given-names></name></person-group><article-title>Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e20932</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0020932</pub-id><?supplied-pmid 21695271?><pub-id pub-id-type="pmid">21695271</pub-id></element-citation></ref><ref id="B76-medicina-57-00217"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Beyond malaria: The inhibition of viruses by artemisinin-type compounds</article-title><source>Biotechnol. Adv.</source><year>2018</year><volume>36</volume><fpage>1730</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.01.001</pub-id><pub-id pub-id-type="pmid">29305894</pub-id></element-citation></ref><ref id="B77-medicina-57-00217"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeid</surname><given-names>S.</given-names></name><name><surname>Alen</surname><given-names>J.</given-names></name><name><surname>Nguyen</surname><given-names>V.H.</given-names></name><name><surname>Pham</surname><given-names>V.C.</given-names></name><name><surname>Meuleman</surname><given-names>P.</given-names></name><name><surname>Pannecouque</surname><given-names>C.</given-names></name><name><surname>Le</surname><given-names>T.N.</given-names></name><name><surname>Neyts</surname><given-names>J.</given-names></name><name><surname>Dehaen</surname><given-names>W.</given-names></name><name><surname>Paeshuyse</surname><given-names>J.</given-names></name></person-group><article-title>Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e81783</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0081783</pub-id><?supplied-pmid 24349127?><pub-id pub-id-type="pmid">24349127</pub-id></element-citation></ref><ref id="B78-medicina-57-00217"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>M.R.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Serrano</surname><given-names>M.A.</given-names></name><name><surname>Castano</surname><given-names>B.</given-names></name><name><surname>Macias</surname><given-names>R.I.</given-names></name><name><surname>Briz</surname><given-names>O.</given-names></name><name><surname>Marin</surname><given-names>J.J.</given-names></name></person-group><article-title>Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an &#x0201d;in vitro&#x0201d; replicative system</article-title><source>Antiviral Res.</source><year>2005</year><volume>68</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2005.07.005</pub-id><?supplied-pmid 16122816?><pub-id pub-id-type="pmid">16122816</pub-id></element-citation></ref><ref id="B79-medicina-57-00217"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzun</surname><given-names>T.</given-names></name><name><surname>Toptas</surname><given-names>O.</given-names></name></person-group><article-title>Artesunate: Could be an alternative drug to chloroquine in COVID-19 treatment?</article-title><source>Chin. Med.</source><year>2020</year><volume>15</volume><fpage>54</fpage><pub-id pub-id-type="doi">10.1186/s13020-020-00336-8</pub-id><pub-id pub-id-type="pmid">32514287</pub-id></element-citation></ref><ref id="B80-medicina-57-00217"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Romero</surname><given-names>M.R.</given-names></name><name><surname>Wolf</surname><given-names>D.G.</given-names></name><name><surname>Stamminger</surname><given-names>T.</given-names></name><name><surname>Marin</surname><given-names>J.J.</given-names></name><name><surname>Marschall</surname><given-names>M.</given-names></name></person-group><article-title>The antiviral activities of artemisinin and artesunate</article-title><source>Clin. Infect. Dis.</source><year>2008</year><volume>47</volume><fpage>804</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1086/591195</pub-id><pub-id pub-id-type="pmid">18699744</pub-id></element-citation></ref><ref id="B81-medicina-57-00217"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>S.</given-names></name><name><surname>Scaccabarozzi</surname><given-names>D.</given-names></name><name><surname>Signorini</surname><given-names>L.</given-names></name><name><surname>Perego</surname><given-names>F.</given-names></name><name><surname>Ilboudo</surname><given-names>D.P.</given-names></name><name><surname>Ferrante</surname><given-names>P.</given-names></name><name><surname>Delbue</surname><given-names>S.</given-names></name></person-group><article-title>The use of antimalarial drugs against viral infection</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>85</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8010085</pub-id><?supplied-pmid 31936284?><pub-id pub-id-type="pmid">31936284</pub-id></element-citation></ref><ref id="B82-medicina-57-00217"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>B.J.</given-names></name><name><surname>Lee</surname><given-names>K.T.</given-names></name><name><surname>Inn</surname><given-names>K.S.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name></person-group><article-title>A survey of therapeutic effects of <italic>Artemisia capillaris</italic> in liver diseases</article-title><source>Evid. Based Complement. Alternat. Med.</source><year>2015</year><volume>2015</volume><pub-id pub-id-type="doi">10.1155/2015/728137</pub-id><?supplied-pmid 26366183?><pub-id pub-id-type="pmid">26366183</pub-id></element-citation></ref><ref id="B83-medicina-57-00217"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolta</surname><given-names>R.</given-names></name><name><surname>Salaria</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Sourirajan</surname><given-names>A.</given-names></name><name><surname>Dev</surname><given-names>K.</given-names></name></person-group><article-title>Phytocompounds of <italic>Rheum emodi</italic>, <italic>Thymus serpyllum</italic> and <italic>Artemisia annua</italic> inhibit COVID-19 binding to ACE2 receptor: In silico approach</article-title><source>Res. Square</source><year>2020</year><pub-id pub-id-type="doi">10.21203/rs.3.rs-30938/v1</pub-id></element-citation></ref><ref id="B84-medicina-57-00217"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Deep</surname><given-names>S.</given-names></name></person-group><article-title>In-silico drug repurposing for targeting SARS-CoV-2 Mpro</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1844058</pub-id></element-citation></ref><ref id="B85-medicina-57-00217"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Anti-SARS-CoV-2 potential of artemisinins in vitro</article-title><source>ACS Infect. Dis.</source><year>2020</year><volume>6</volume><fpage>2524</fpage><lpage>2531</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00522</pub-id><pub-id pub-id-type="pmid">32786284</pub-id></element-citation></ref><ref id="B86-medicina-57-00217"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehailia</surname><given-names>M.</given-names></name><name><surname>Chemat</surname><given-names>S.</given-names></name></person-group><article-title>Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: Potential repurposing of artenimol for COVID-19</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1796809</pub-id></element-citation></ref><ref id="B87-medicina-57-00217"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>K.K.</given-names></name><name><surname>Sharma</surname><given-names>L.</given-names></name><name><surname>Pandey</surname><given-names>N.</given-names></name><name><surname>Meena</surname><given-names>R.P.</given-names></name><name><surname>Rai</surname><given-names>S.P.</given-names></name></person-group><article-title>Repurposing <italic>Artemisia annua</italic> L. flavonoids, artemisinin and its derivatives as potential drugs against novel coronavirus (SARS-nCoV) as revealed by in-silico studies</article-title><source>Int. J. Appl. Sci. Biotechnol.</source><year>2020</year><volume>84</volume><fpage>374</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.3126/ijasbt.v8i4.33667</pub-id></element-citation></ref><ref id="B88-medicina-57-00217"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomic</surname><given-names>N.</given-names></name><name><surname>Pojskic</surname><given-names>L.</given-names></name><name><surname>Kalajdzic</surname><given-names>A.</given-names></name><name><surname>Ramic</surname><given-names>J.</given-names></name><name><surname>Kadric</surname><given-names>N.L.</given-names></name><name><surname>Ikanovic</surname><given-names>T.</given-names></name></person-group><article-title>Screening of preferential binding affinity of selected natural compounds to SARS-CoV-2 proteins using in silico methods</article-title><source>EJMO</source><year>2020</year><volume>4</volume><fpage>319</fpage><lpage>323</lpage></element-citation></ref><ref id="B89-medicina-57-00217"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alazmi</surname><given-names>M.</given-names></name><name><surname>Motwalli</surname><given-names>O.</given-names></name></person-group><article-title>Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates</article-title><source>J. Mol. Model.</source><year>2020</year><volume>26</volume><fpage>338</fpage><pub-id pub-id-type="doi">10.1007/s00894-020-04599-8</pub-id><pub-id pub-id-type="pmid">33175236</pub-id></element-citation></ref><ref id="B90-medicina-57-00217"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilmore</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ramirez</surname><given-names>S.</given-names></name><name><surname>Pham</surname><given-names>L.V.</given-names></name><name><surname>Fahn&#x000f8;e</surname><given-names>U.</given-names></name><name><surname>Feng</surname><given-names>S.</given-names></name><name><surname>Offersgaard</surname><given-names>A.</given-names></name><name><surname>Trimpert</surname><given-names>J.</given-names></name><name><surname>Bukh</surname><given-names>J.</given-names></name><name><surname>Osterrieder</surname><given-names>K.</given-names></name><etal/></person-group><article-title>In vitro efficacy of artemisinin-based treatments against SARS-CoV-2</article-title><source>BioRxiV</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.10.05.326637</pub-id></element-citation></ref><ref id="B91-medicina-57-00217"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>M.S.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Fidock</surname><given-names>D.A.</given-names></name><name><surname>Polyak</surname><given-names>S.J.</given-names></name><name><surname>Wagoner</surname><given-names>J.</given-names></name><name><surname>Towler</surname><given-names>M.J.</given-names></name><name><surname>Weathers</surname><given-names>P.J.</given-names></name></person-group><article-title><italic>Artemisia annua</italic> L. extracts prevent in vitro replication of SARS-CoV-2</article-title><source>BioRxiV</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2021.01.08.425825</pub-id></element-citation></ref><ref id="B92-medicina-57-00217"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendrot</surname><given-names>M.</given-names></name><name><surname>Duflot</surname><given-names>I.</given-names></name><name><surname>Boxberger</surname><given-names>M.</given-names></name><name><surname>Delandre</surname><given-names>O.</given-names></name><name><surname>Jardot</surname><given-names>P.</given-names></name><name><surname>Le Bideau</surname><given-names>M.</given-names></name><name><surname>Andreani</surname><given-names>J.</given-names></name><name><surname>Fonta</surname><given-names>I.</given-names></name><name><surname>Mosnier</surname><given-names>J.</given-names></name><name><surname>Rolland</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate</article-title><source>Int J. Infect. Dis.</source><year>2020</year><volume>99</volume><fpage>437</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.08.032</pub-id><?supplied-pmid 32805422?><pub-id pub-id-type="pmid">32805422</pub-id></element-citation></ref><ref id="B93-medicina-57-00217"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>S.</given-names></name><name><surname>Bustamante</surname><given-names>L.</given-names></name><name><surname>Haynes</surname><given-names>R.K.</given-names></name><name><surname>Staines</surname><given-names>H.M.</given-names></name></person-group><article-title>Artemisinins: Their growing importance in medicine</article-title><source>Trends Pharmacol. Sci.</source><year>2008</year><volume>29</volume><fpage>520</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2008.07.004</pub-id><?supplied-pmid 18752857?><pub-id pub-id-type="pmid">18752857</pub-id></element-citation></ref><ref id="B94-medicina-57-00217"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>A potential treatment of COVID-19 with TGF-beta blockade</article-title><source>Int J. Biol. Sci.</source><year>2020</year><volume>16</volume><fpage>1954</fpage><lpage>1955</lpage><pub-id pub-id-type="doi">10.7150/ijbs.46891</pub-id><pub-id pub-id-type="pmid">32398962</pub-id></element-citation></ref><ref id="B95-medicina-57-00217"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Yuan</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: An open-label, non-randomized, and controlled trial</article-title><source>Int J. Antimicrob. Agents</source><year>2020</year><volume>18</volume><fpage>106216</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.106216</pub-id><?supplied-pmid 33152450?><pub-id pub-id-type="pmid">33152450</pub-id></element-citation></ref><ref id="B96-medicina-57-00217"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R.M.</given-names></name><name><surname>Lippman</surname><given-names>S.M.</given-names></name></person-group><article-title>Shining light on the COVID-19 pandemic: A vitamin D receptor checkpoint in defense of unregulated wound healing</article-title><source>Cell Metab.</source><year>2020</year><volume>32</volume><fpage>704</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.09.007</pub-id><?supplied-pmid 32941797?><pub-id pub-id-type="pmid">32941797</pub-id></element-citation></ref><ref id="B97-medicina-57-00217"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uckun</surname><given-names>F.M.</given-names></name><name><surname>Hwang</surname><given-names>L.</given-names></name><name><surname>Trieu</surname><given-names>V.</given-names></name></person-group><article-title>Selectively targeting TGF-&#x003b2; with trabedersen/OT-101 in treatment of evolving and mild ARDS in COVID-19</article-title><source>Clin. Investig.</source><year>2020</year><volume>10</volume><fpage>167</fpage><lpage>176</lpage></element-citation></ref><ref id="B98-medicina-57-00217"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>N.</given-names></name></person-group><article-title>Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-beta signaling in breast cancer</article-title><source>J. Exp. Clin. Cancer Res.</source><year>2018</year><volume>37</volume><fpage>282</fpage><pub-id pub-id-type="doi">10.1186/s13046-018-0960-7</pub-id><pub-id pub-id-type="pmid">30477536</pub-id></element-citation></ref><ref id="B99-medicina-57-00217"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>An</surname><given-names>P.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Therapeutic effect of artemisinin on lupus nephritis mice and its mechanisms</article-title><source>Acta Biochimica et Biophysica Sinica</source><year>2010</year><volume>42</volume><fpage>916</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1093/abbs/gmq101</pub-id><?supplied-pmid 21106771?><pub-id pub-id-type="pmid">21106771</pub-id></element-citation></ref><ref id="B100-medicina-57-00217"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Y.H.</given-names></name><name><surname>Gao</surname><given-names>L.W.</given-names></name><name><surname>Li</surname><given-names>X.Y.</given-names></name><name><surname>Jin</surname><given-names>Q.X.</given-names></name><name><surname>Wang</surname><given-names>Y.Y.</given-names></name><name><surname>Xu</surname><given-names>Y.Y.</given-names></name><name><surname>Jin</surname><given-names>F.</given-names></name><name><surname>Lu</surname><given-names>S.L.</given-names></name><name><surname>Wei</surname><given-names>M.J.</given-names></name></person-group><article-title>Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo</article-title><source>Int. Immunopharmacol.</source><year>2019</year><volume>70</volume><fpage>110</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2019.01.041</pub-id><?supplied-pmid 30798159?><pub-id pub-id-type="pmid">30798159</pub-id></element-citation></ref><ref id="B101-medicina-57-00217"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trieu</surname><given-names>V.</given-names></name><name><surname>Saund</surname><given-names>S.</given-names></name><name><surname>Rahate</surname><given-names>P.S.</given-names></name><name><surname>Barge</surname><given-names>V.B.</given-names></name><name><surname>Nalk</surname><given-names>K.S.</given-names></name><name><surname>Windlass</surname><given-names>H.</given-names></name><name><surname>Uckun</surname><given-names>F.M.</given-names></name></person-group><article-title>Targeting TGF-&#x003b2; pathway with COVID-19 drug candidate ARTIVeda/PulmoHeal accelerates recovery from mild-moderate COVID-19</article-title><source>MedRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2021.01.24.21250418</pub-id></element-citation></ref><ref id="B102-medicina-57-00217"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Snader</surname><given-names>K.M.</given-names></name></person-group><article-title>Natural products in drug discovery and development</article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1021/np9604893</pub-id><?supplied-pmid 9014353?><pub-id pub-id-type="pmid">9014353</pub-id></element-citation></ref><ref id="B103-medicina-57-00217"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haq</surname><given-names>F.U.</given-names></name><name><surname>Roman</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>K.</given-names></name><name><surname>Rahman</surname><given-names>S.U.</given-names></name><name><surname>Shah</surname><given-names>S.M.A.</given-names></name><name><surname>Suleman</surname><given-names>N.</given-names></name><name><surname>Ullah</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name><name><surname>Ullah</surname><given-names>W.</given-names></name></person-group><article-title><italic>Artemisia annua</italic>: Trials are needed for COVID-19</article-title><source>Phytother. Res.</source><year>2020</year><volume>34</volume><fpage>2423</fpage><lpage>2424</lpage><pub-id pub-id-type="doi">10.1002/ptr.6733</pub-id><pub-id pub-id-type="pmid">32424845</pub-id></element-citation></ref><ref id="B104-medicina-57-00217"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>E.M.</given-names></name></person-group><article-title>Synergy and other interactions in phytomedicines</article-title><source>Phytomedicine</source><year>2001</year><volume>8</volume><fpage>401</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1078/0944-7113-00060</pub-id><pub-id pub-id-type="pmid">11695885</pub-id></element-citation></ref><ref id="B105-medicina-57-00217"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasoanaivo</surname><given-names>P.</given-names></name><name><surname>Wright</surname><given-names>C.W.</given-names></name><name><surname>Willcox</surname><given-names>M.L.</given-names></name><name><surname>Gilbert</surname><given-names>B.</given-names></name></person-group><article-title>Whole plant extracts versus single compounds for the treatment of malaria: Synergy and positive interactions</article-title><source>Malar. J.</source><year>2011</year><volume>10</volume><fpage>S4</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-10-S1-S4</pub-id><?supplied-pmid 21411015?><pub-id pub-id-type="pmid">21411015</pub-id></element-citation></ref><ref id="B106-medicina-57-00217"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raskin</surname><given-names>I.</given-names></name><name><surname>Ripoll</surname><given-names>C.</given-names></name></person-group><article-title>Can an apple a day keep the doctor away?</article-title><source>Curr. Pharm. Des.</source><year>2004</year><volume>10</volume><fpage>3419</fpage><lpage>3429</lpage><pub-id pub-id-type="doi">10.2174/1381612043383070</pub-id><?supplied-pmid 15544525?><pub-id pub-id-type="pmid">15544525</pub-id></element-citation></ref><ref id="B107-medicina-57-00217"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Ulrich-Merzenich</surname><given-names>G.</given-names></name></person-group><article-title>Synergy research: Approaching a new generation of phytopharmaceuticals</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>97</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.12.018</pub-id><?supplied-pmid 19211237?><pub-id pub-id-type="pmid">19211237</pub-id></element-citation></ref><ref id="B108-medicina-57-00217"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thevarajan</surname><given-names>I.</given-names></name><name><surname>Buising</surname><given-names>K.L.</given-names></name><name><surname>Cowie</surname><given-names>B.C.</given-names></name></person-group><article-title>Clinical presentation and management of COVID-19</article-title><source>Med. J. Aust.</source><year>2020</year><volume>213</volume><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.5694/mja2.50698</pub-id><pub-id pub-id-type="pmid">32677734</pub-id></element-citation></ref><ref id="B109-medicina-57-00217"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipman</surname><given-names>M.</given-names></name><name><surname>Chambers</surname><given-names>R.C.</given-names></name><name><surname>Singer</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>J.S.</given-names></name></person-group><article-title>SARS-CoV-2 pandemic: Clinical picture of COVID-19 and implications for research</article-title><source>Thorax</source><year>2020</year><volume>75</volume><fpage>614</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2020-215024</pub-id><pub-id pub-id-type="pmid">32461230</pub-id></element-citation></ref><ref id="B110-medicina-57-00217"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecchini</surname><given-names>R.</given-names></name><name><surname>Cecchini</surname><given-names>A.L.</given-names></name></person-group><article-title>SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression</article-title><source>Med. Hypotheses</source><year>2020</year><volume>143</volume><fpage>110102</fpage><pub-id pub-id-type="doi">10.1016/j.mehy.2020.110102</pub-id><?supplied-pmid 32721799?><pub-id pub-id-type="pmid">32721799</pub-id></element-citation></ref><ref id="B111-medicina-57-00217"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>K.</given-names></name><name><surname>Chan</surname><given-names>D.</given-names></name><name><surname>Watermeyer</surname><given-names>T.</given-names></name></person-group><article-title>The cognitive consequences of the COVID-19 epidemic: Collateral damage?</article-title><source>Brain Commun.</source><year>2020</year><volume>2</volume><fpage>fcaa069</fpage><pub-id pub-id-type="doi">10.1093/braincomms/fcaa069</pub-id><?supplied-pmid 33074266?><pub-id pub-id-type="pmid">33074266</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="medicina-57-00217-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">medicina-57-00217-t001_Table 1</object-id><label>Table 1</label><caption><p>Ayurveda describes two species <italic>A. absinthium</italic> and <italic>A</italic>. <italic>maritima</italic> that vary slightly in their qualities and actions. Both plants popularly known as Mugwort are revered in Ayurveda for their anti-infectious and insecticidal (<italic>krimighna</italic>) properties [<xref rid="B20-medicina-57-00217" ref-type="bibr">20</xref>].</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. absinthium</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. maritima</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Names</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mugwort, Indian wormseed, Damanaka, Davana, Dona, Douna, Davanamu</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Old woman, Mugwort, worm seed, Kirmani, Chuhara, Dirmana</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Qualities (<italic>guna</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light (laghu), Dry (ruksha), Hot (teekshana)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Light (laghu), Dry (ruksha), Hot (teekshana)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Taste (<italic>rasa</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asringent (kashaya), Bitter (tikta)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pungent (katu), Bitter (tikta)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potency (<italic>veerya</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hot (Ushna)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hot (Ushna)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Post-digestive effect (<italic>vipaka</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pungent (katu)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pungent (katu)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Special Intrinsic Action (<italic>prabhava</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal (<italic>krimighna</italic>), anti-pyretic (<italic>jwaraghna</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticidal (<italic>krimighna</italic>), anti-pyretic (<italic>jwaraghna</italic>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Optimizes kapha, pitta and vata (tridosha shamaka), anti-infectious, improves digestion, wound healing, respiratory and liver tonic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Optimizes kapha and vata (Kaphavata shamaka), anti-infectious, improves digestion, wound healing</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parts of plant used</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root, leaves, bark</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root, leaves, bark</td></tr></tbody></table></table-wrap><table-wrap id="medicina-57-00217-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">medicina-57-00217-t002_Table 2</object-id><label>Table 2</label><caption><p>The pharmacological actions and properties of a subset of Artemisia species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Uses</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phytochemicals Isolated</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>absinthium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cardiac stimulant, anthelmintic, liver function, memory booster</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesquiterpene lactones, polyphenolic compounds, flavonoids, tannins, lignins [<xref rid="B23-medicina-57-00217" ref-type="bibr">23</xref>,<xref rid="B24-medicina-57-00217" ref-type="bibr">24</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. abrotanum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insecticide, liver conditions</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonols, tannins, coumarins [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B8-medicina-57-00217" ref-type="bibr">8</xref>,<xref rid="B25-medicina-57-00217" ref-type="bibr">25</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>afra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">coughs, colds, malaria, diabetes, bladder and kidney disorders</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">monoterpenoids, sesquiterpenes, glaucolides, guaianolides; flavonoids [<xref rid="B23-medicina-57-00217" ref-type="bibr">23</xref>,<xref rid="B26-medicina-57-00217" ref-type="bibr">26</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>annua</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fever, malaria, fibrosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, sesquiterpene lactones, phenolic compounds, flavones [<xref rid="B23-medicina-57-00217" ref-type="bibr">23</xref>,<xref rid="B27-medicina-57-00217" ref-type="bibr">27</xref>,<xref rid="B28-medicina-57-00217" ref-type="bibr">28</xref>,<xref rid="B29-medicina-57-00217" ref-type="bibr">29</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>asiatica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cancer, inflammation, infections and ulcers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, flavones, alkaloids [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B30-medicina-57-00217" ref-type="bibr">30</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. arborescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory, Antihistaminic, Blood decongestant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenes, flavone, fatty acids [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B31-medicina-57-00217" ref-type="bibr">31</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>douglasiana</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">premenstrual syndrome and dysmenorrhea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monoterpenes, sesquiterpene lactones [<xref rid="B23-medicina-57-00217" ref-type="bibr">23</xref>,<xref rid="B32-medicina-57-00217" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>dracunculus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antidiabetic and anticoagulant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, coumarins, polyphenolic compounds, glucoside [<xref rid="B33-medicina-57-00217" ref-type="bibr">33</xref>,<xref rid="B34-medicina-57-00217" ref-type="bibr">34</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>judaica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastrointestinal disorders</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile components, phenolic compounds [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B35-medicina-57-00217" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>maritima</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">anthelmintic, liver function, GI issues</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, fatty acids, polyphenolic compounds, sesquiterpene lactones [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B23-medicina-57-00217" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>scoparia</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">antibacterial, antiseptic, antipyretic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, fatty acids, coumarins, pyrogallol tannins, cholagogic components, flavonoids, flavones [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B36-medicina-57-00217" ref-type="bibr">36</xref>,<xref rid="B37-medicina-57-00217" ref-type="bibr">37</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A. t</italic>
<italic>ripartite</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cold, sore throats, tonsillitis, headaches and wounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guaianolides, polysaccharides [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B38-medicina-57-00217" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>verlotorum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, fatty acids [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B39-medicina-57-00217" ref-type="bibr">39</xref>,<xref rid="B40-medicina-57-00217" ref-type="bibr">40</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>vestita</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inflammatory diseases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oils, flavonoids [<xref rid="B41-medicina-57-00217" ref-type="bibr">41</xref>,<xref rid="B42-medicina-57-00217" ref-type="bibr">42</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>A.</italic>
<italic>vulgaris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">analgesic, anti-inflammatory, antispasmodic and liver disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenes, coumarins [<xref rid="B6-medicina-57-00217" ref-type="bibr">6</xref>,<xref rid="B43-medicina-57-00217" ref-type="bibr">43</xref>].</td></tr></tbody></table></table-wrap></floats-group></article>